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Raman spectroscopy is a molecular vibrational spectroscopic technique that is capable of 
optically probing the biomolecular changes associated with disease transformation. To 
effectively translate molecular differences captured in Raman spectra between different 
tissue types into clinically valuable diagnostic information for clinicians, chemometrics 
would need to be deployed for developing effective diagnostic algorithms for Raman 
spectroscopic diagnosis of precancer and cancers. However, most of the chemometrices 
(principal component analysis (PCA)) applied for Raman tissue diagnosis cannot 
adequately provide the physical meanings of component spectra for tissue classification 
This dissertation presents the investigation on the diagnostic utility of near infrared (NIR) 
Raman spectroscopy with recursive partitioning techniques such as classification and 
regression trees (CART), and random forests to construct clinically interpretable 
diagnostic algorithm for tissue Raman classification.  
 
A rapid-acquisition dispersive-type NIR Raman system was utilized for tissue Raman 
spectroscopic measurements at 785 nm laser excitation. A total of 146 tissue samples 
obtained from 70 patients who underwent endoscopy investigation or surgical operation 
were used in this study. The histopathogical examinations showed that 94 were gastric 
tissues (55 normal, 21 dysplastic, and 18 cancerous), and 50 were laryngeal tissues (20 




 CART was explored to be used together with NIR Raman spectroscopy for gastric cancer 
diagnosis. CART achieved a predictive sensitivity and specificity of 88.9% and 92.9%, 
respectively, for separating cancer from normal. In addition, CART also determined 
tissue Raman peaks at 875 and 1745 cm-1 to be two of the most significant features in the 
entire Raman spectral range to discriminate gastric cancer from normal tissue. This 
affirmed the utility of CART to be used for NIR Raman spectroscopy detection of cancer 
tissues. 
 
To improve diagnostic performance (e.g., stability) of CART, the random ensemble 
approach (i.e., random forests) was further utilized. Random forests yielded a diagnostic 
sensitivity of 88.0% and specificity of 91.4% for laryngeal malignancy identification, and 
also provided variables importance plot that facilitates correlation of significant Raman 
spectral features with cancer transformation. These confirmed the diagnostic potential of 
random forests with NIR Raman spectroscopy for detection of malignancy occurring in 
the internal organs (i.e., larynx).  
 
Comprehensive evaluation of the performance of the empirical approach that utilizes 
Raman peak intensity ratio, PCA-linear discriminant analysis (LDA), and random forests 
algorithm was also carried out. Raman peak intensity ratios representing biomolecular 
signals for collagen, proteins and lipids achieved diagnostic accuracy of approximately 
88% for NIR Raman spectroscopic detection of gastric dysplasia from the normal gastric 
tissues. Further investigation on the use of PCA-LDA achieved obtained a diagnostic 
accuracy of 93%, while random forests achieved diagnostic accuracy of 90% for gastric 
  XIII
 
 dysplasia detection. Receiver operating characteristics (ROC) curves further confirmed 
that PCA-LDA and random forests techniques have comparable overall diagnostic 
accuracy rate which are more superior compared to the empirical approach.  
 
Overall, this dissertation demonstrates that NIR Raman spectroscopy in conjunction with 
powerful chemometric techniques such as random forests have the potential to generate 
interpretable clinical Raman information, and to yield high diagnostic accuracy 
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 CHAPTER 1  
INTRODUCTION 
1.1 INTRODUCTION AND MOTIVATION 
As the majority of cancers (~90%) are epithelial in origin, early detection and localization 
with immediate removal (e.g., surgery) of malignant tumors is critical towards decreasing 
the mortality rate of the patients [1]. However, early identification of cancer lesions in the 
lining of the internal organs such as stomach and larynx can be very challenging through 
conventional diagnostic method such as the white-light endoscope which heavily relies 
on the visual examination of gross morphological changes of tissue, leading to a poor 
diagnostic accuracy [1]. Endoscopic biopsy currently remains the standard approach for 
most cancer diagnosis, but is invasive and impractical for screening high-risk patients 
who may have multiple suspicious lesions [2]. Hence, it is highly desirable to develop 
noninvasive optical diagnostic techniques for direct assessments of biochemical 
information of suspicious lesion sites during clinical examinations. 
 
Optical spectroscopic methods such as light scattering spectroscopy, fluorescence 
spectroscopy, and Raman spectroscopy have been comprehensively investigated for 
cancer and precancer diagnosis and evaluation [1-24]. Raman spectroscopy is a 
vibrational spectroscopic technique that is capable of probing specific biochemical 
fingerprints of biological tissues based on inelastic light scattering processes [5]. This 
technique has shown great promise for detecting molecular alterations associated with 
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 diseased transformation [5-12]. With the use of near-infrared (NIR) lasers as excitation 
light sources, NIR Raman spectroscopy holds significant advantages in that water 
exhibits very low absorption at the working wavelength range, and tissues exhibit far less 
autofluorescence than with visible light excitation [12]. Less water absorption makes it 
easy to detect other tissue components and results in deeper light penetration into the 
tissue [12]. As a result, NIR Raman spectroscopy has been widely studied for early 
detection of pre-malignancy and malignancy in a number of organ sites [1, 5, 6, 15], 
including the stomach [14, 25-28] and larynx [10, 21, 24].  
 
In order to convert molecular differences subtly reflected in Raman spectra between 
different tissues types into valuable diagnostic information for clinicians, different 
statistical techniques have been explored  in developing effective diagnostic algorithms 
for Raman spectroscopic of precancer and cancer diagnosis [5, 6, 20, 29, 30]. Due to the 
complexities of the biological tissues, multivariate statistical techniques (e.g., principal 
component  analysis (PCA)), which are able to take into account of the whole range of 
Raman spectral features of the tissue, have often been applied to construct high 
diagnostic accuracy algorithms for different tissue type classification [7-9, 11-13]. 
However, most of these multivariate statistical techniques (e.g., PCA) could not 
adequately furnish the clinicians with physical meanings of diagnostic features derived 
for tissue characterization [29]; thereby, the development of robust algorithms, which not 
only produce a high predicted diagnostic accuracy, but also provide useful biomolecular 
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 diagnostic information from the high dimensional Raman spectral datasets, is highly 
desirable. 
1.2 SPECIFIC AIMS OF THE DISSERTATION 
The primary aim of this dissertation was to evaluate the clinical potential of NIR Raman 
spectroscopy combined with different chemometric algorithms, especially the recursive 
partitioning techniques for detection of precancer and cancer tissues. Hence, the 
following specific aims were developed: 
 
1. Assessment on the feasibility of using a rapid fiber-optic NIR Raman spectroscopy 
system for clinical evaluation of human tissues, and to characterize the Raman properties 
of internal organ tissues (i.e., gastric and laryngeal tissue).  
 
2. Exploration on the potential of classification and regression trees techniques (CART) 
for use with NIR Raman spectroscopy in stomach cancer diagnosis.   
 
3. Investigation on the ensemble technique for recursive partitioning algorithms (i.e., 
random forests) in identification of laryngeal carcinoma from normal laryngeal tissues 
with the use of NIR Raman spectroscopy.  
 





 5. Comprehensive comparison of the potential of empirical method (i.e., intensity ratio) 
with the multivariate statistical techniques (i.e., PCA and linear discriminant analysis 
(LDA)) to be used together with NIR Raman spectroscopy for discrimination of gastric 
dysplasia from normal.  
 
6. Evaluation of random forests technique together with empirical method (i.e., intensity 
ratio) and the multivariate statistical techniques (i.e., PCA-LDA) for NIR Raman 
spectroscopic detection of gastric dysplasia.  
 
1.3 ORGANIZATION OF THE DISSERTATION 
The study is structured into three main parts. This dissertation begins with providing a 
detailed background on the Raman instrumentations, the preprocessing method and the 
types of human tissues samples which have been employed throughout the entire study. 
The second part of this study is focused on the development of recursive partitioning 
algorithms from the construction of a single classification tree (i.e., CART), to an 
ensemble of approximately 1000 classification trees (i.e., random forests) for cancer 
tissue diagnosis using NIR Raman spectroscopy. The third part is to assess the 
performance of random forests with respect to two commonly utilized diagnostic 
algorithms (i.e., intensity ratio and PCA-LDA) for NIR Raman spectroscopy tissue 
diagnosis. A thorough evaluation of the three different diagnostic algorithms was 
conducted through the use of precancer tissues to also affirm the diagnostic utility of 
random forests with NIR Raman spectroscopy for precancer diagnosis.  
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 Specifically, Chapter 2 provides the overview of Raman technique and its development 
for precancer and cancer diagnosis, extensive review on the application of Raman 
technology for pre-malignancy and malignancy detection in different organ sites, and the 
summary of the various diagnostic algorithms which have been utilized to understand and 
translate Raman molecular signals into clinically useful information. Chapter 3 illustrates 
the hardware instrumentation, data preprocessing techniques and the type of tissues that 
have been utilized in this dissertation. Chapter 4 gives the introduction of recursive 
partitioning technique (i.e., CART) for NIR Raman spectroscopy diagnosis of cancer 
tissue. In chapter 5, application of the ensemble recursive partitioning algorithms (i.e., 
random forests) for NIR Raman spectroscopic diagnosis of cancer tissue will be shown. 
Chapter 6 describes the empirical approach (i.e., intensity ratio) which has been 
commonly utilized to construct a simple, yet useful diagnostic algorithm for detection of 
precancer tissues using Raman spectroscopy. Chapter 7 further demonstrates the 
diagnostic utility of multivariate statistical techniques (i.e., PCA-LDA) in conjunction 
with Raman spectroscopy for diagnosing precancer tissue. Chapter 8 verifies the 
diagnostic performance of random forests for precancer tissue in comparison with the 
empirical and multivariate statistical techniques. The final chapter concludes the work in 






 CHAPTER 2  
OVERVIEW ON RAMAN SPECTROSCOPY FOR PRECANCER AND 
CANCER DIAGNOSIS 
The discoverer of the Raman effect was Chandrasekhara Venkata Raman who published 
in Nature entitled ‘The color of the sea’, in which he showed that the color of the ocean is 
due to scattering of light [22]. He continued his investigation on scattering of light and 
eventually discovered the Raman effect in 1928 [31]. The Raman effect is an inelastic 
light scattering process whereby a very small proportion of incident photons are scattered 
(~1 in 108) with a corresponding change in frequency. The difference between the 
incident and scattered frequencies corresponds to the vibrational modes of molecules 
participating in the interaction. These Raman scattered light can be collected by a 
spectrometer and displayed as a ‘spectrum’, in which its intensity is displayed as a 
function of its frequency change.  
 
As most biomolecules are Raman-active scatterers, each with its own spectral fingerprint, 
and Raman spectra usually exhibit sharp spectral features that are characteristic for 
specific molecular structures and conformations of tissue, it can provide more specific 
molecular information about a given tissue or disease state [5].  Therefore, in the past 
decade, Raman spectroscopy has been comprehensively investigated for precancer and 
cancer diagnosis and evaluation in humans including in the bladder, brain, breast, cervix, 
gastrointestinal tract, head and neck, lung, oral, skin, and prostate. Many of these studies 
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 have shown that specific spectral features of Raman spectra could be used to correlate 
with the molecular and structural changes of tissue associated with neoplastic 
transformation [1, 5-21, 32-34]. In combination with multivariate statistical analysis such 
as PCA and LDA, NIR Raman spectroscopy has demonstrated promising diagnostic 
accuracy (~90%) for Raman detection of precancer and cancer tissues in different organ 
sites (i.e., stomach) [1,2,6-9,12,13,15,16, 21,24].  
 
The present chapter presents an overview on the development of Raman technology for 
cancer tissue diagnosis, and a review on the different analytical algorithms commonly 
applied for tissue Raman diagnosis so as to provide comprehensive background 
knowledge on this project work.  
2.1 TECHNOLOGICAL ADVANCEMENT FOR CLINICAL RAMAN SPECTROSCOPY 
SYSTEM 
As Raman scattering (inelastic scattering) is inherently very weak, typically 10-9 to 10-6 
of the intensity of the Rayleigh background (elastic scattering), intense monochromatic 
excitation and a sensitive detector are critical towards obtaining observable Raman 
signals [22]. Hence, advancement of Raman spectroscopy for biomedical application only 
began with the development of lasers and sensitive detector in 1960s [22, 35, 36].  
 
The first laser-based Raman spectroscopy system for biological application arises from 
the use of visible (VIS) excitation with a photomultiplier or multi-channel optical 
detector used to detect scattered photons in the frequency range of interest [37]. 
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 However, as the techniques for biological application progressed and due to technological 
advancement, NIR laser excitation gradually became the frequent choice for Raman 
spectroscopic investigation on biological tissues [22]. This section shall cover the 
development of NIR Raman technology for biological tissue diagnosis.  
2.1.1 EXCITATION WAVELENGTH STRATEGIES FOR BIOMEDICAL RAMAN 
SPECTROSCOPY 
The use of different excitation lights such as ultraviolet (UV), VIS and NIR light for 
Raman spectroscopic studies [22] will generate different light scattering, absorption and 
emission phenomenon in biological and biomedical systems. In this sub-section, a 
summary on the investigation of the different laser wavelength for Raman spectroscopy 
to be used in biomedical application will be presented. 
2.1.1.1 VISIBLE (VIS) AND NEAR ULTRA-VIOLET (UV) EXCITATION 
Most biological tissues exhibit significant autofluorescence signals which will severely 
interfere with weak Raman signals with the use of VIS or near-UV excited Raman 
spectroscopy. Hence, in order to reduce background autofluorescence signals emitted 
from biological tissues, the samples had to be photobleached (pre-irradiated) before 
recording reliable Raman signals [38]. To date, only corneal collagen and lens proteins 
have been found to produce very little or no autofluorescence signal with VIS excited 
Raman spectroscopy [22]. As a result, to avoid photobleaching biological tissues which 
would change the tissue biomolecular conformation and structures, and circumvent the 
strong autofluorescence signals with the use of VIS or near-UV excited Raman 
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 spectroscopy, deep UV (>300nm) and NIR excited Raman spectroscopy, instead, could 
be utilized for biological application [38, 39].  
2.1.1.2 DEEP UV RESONANCE RAMAN SPECTROSCOPY 
The resonance Raman effect occurs when the excitation laser wavelength is in close 
proximity with an electronic transition (i.e., absorption band) of the analyte. Thus, by 
selecting the appropriate excitation wavelength, Raman bands of molecules can be 
selectively greatly enhanced in the midst of a myriad of overlapping vibrations from 
various tissue components [22]. On top of the resonance enhancement effect, the 
scattering cross-section is also increased. These combined effects lead to tremendous 
increase in Raman intensity, which allow detection of biomolecules in very low 
concentration. As the penetration of UV light on biological tissue is shallow (<50 μm), it 
can also effectively target biomolecules on the superficial tissue surface layer, such as the 
epithelial tissue where most cancerous lesions often originate from. However, there is a 
potential problem associated with the photomutagenicity on the use of UV light on 
biological tissues [22].  
2.1.1.3 NEAR-INFRARED (NIR) EXCITATION RAMAN SPECTROSCOPY 
The autofluorescence signal decreases very rapidly at longer excitation wavelengths, and 
most biological tissues exhibit little or no autofluorescence signals when excited in the 
NIR spectral range [38]. In addition, NIR light has a relatively small extinction 
coefficient (absorption coefficient) in biological tissues, and so facilitating a deeper light 
penetration, in the order of millimeters, which can probe larger tissue volume information 
[40]. The small absorption coefficient will also not result in photo-degradation of the 
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 interrogated biological samples [22]. Furthermore, water is a relatively weak absorber in 
the NIR. Thus, even though biological cells are usually composed of about 70-95% of 
water by weight, water will not significantly interfere with NIR Raman spectroscopy for 
biological application [40]. On top of this, the use of NIR excitation light is compatible to 
be used with fiber-optic technology, which makes NIR excitation Raman spectroscopy 
technique highly possible to directly collect remote in situ tissue signals from all parts of 
human body [23]. As a result, in comparison with UV and VIS excitation Raman 
spectroscopy, NIR excited Raman spectroscopy provides the most benefits for biological 
application. Therefore, most of the Raman spectroscopic studies on biomedical 
application are centered on the use of NIR light.  
 
The earliest form of NIR Raman spectroscopy system (i.e., Fourier-Transform (FT) 
Raman) primarily uses 1064 nm from a neodymium-doped yttrium aluminium garnet 
(Nd:YAG) laser as the excitation source, a cooled indium gallium arsenide (InGaAs) 
detector, and a Michelson interferometer system [41-44]. By working with 1064 nm in 
the NIR, background autofluorescence is almost entirely eliminated [22]. However, the 
signal-to-noise ratio (S/N) produced from the NIR FT Raman spectrosocpy is limited by 
both reduced scattering  cross-section at the 1064 nm excitation wavelength, and the 
intrinsic noise associated with the InGaAs detectors in the spectral range of 1100 – 1350 
nm (~Raman shift of 300-200 cm-1) [22]. Hence, long integration time of about 30-60 
mins for acquiring high-quality Raman signal from biological tissue is often required for 
the use of NIR FT Raman 41-43]. Long acquisition time for collection of reliable Raman 
signal is the main drawback for NIR FT Raman to be employed for biomedical 
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 application. On top of this, the throughout advantage of interferometer-based FT Raman 
spectroscopy is lost due to the incompatibility of the numerical aperture (NA) of the 
system with the optical fibers which can be used for clinical application [22]. This greatly 
hinders the development of NIR FT Raman system for remote spectroscopic clinical 
application.   
 
With technological advancement, a more efficient NIR Raman system, which can provide 
a high S/N, could be achieved, and so greatly shortened the integration time needed to 
record a reliable Raman signal. The following subsections (Section 2.1.2 – 2.1.5) will 
elaborate more in details on the different essential Raman components which are critical 
towards the development of NIR Raman spectroscopy for biomedical diagnosis.  
2.1.2 CHARGED-COUPLED DEVICE (CCD) 
As the noise level of a CCD-based NIR Raman system is signal shot noise limited, while 
the noise level of an InGaAs-based NIR Raman system is limited by detector noise (e.g. 
dark current and read-out noise) which is several orders of magnitude larger than the 
CCD-based NIR Raman system, the CCD-based NIR Raman system could result in a 
higher S/N [22]. Hence, in order to achieve a better performance, most NIR Raman 
works progressively focused on the CCD-based NIR Raman system.  
 
There are a variety of different types of CCD such as front illuminated, thinned back-
illuminated and front- or back-illuminated deep depletion CCD which are used for 
different applications [22]. For Raman study, as the Raman signal is very weak, a highly 
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 sensitive CCD which can obtain the highest possible photon detection efficiency is the 
most important criteria. Thus, a thinned back-illuminated CCD detector is often the 
choice to be used for Raman system as it has higher quantum efficiencies than a front-
illuminated CCD. However, in the NIR spectral region, thinned back-illuminated CCD 
detectors introduce the etalon effect [22]. The newer deep-depletion back-illuminated 
CCD is specially fabricated and optimized for the NIR light to minimize this elatoning 
effect. As a result, most current Raman clinical systems employ the use of the deep-
depletion back-illuminated CCD detector to maximize quantum efficiency and minimize 
etalon artifacts. 
 
One important factor to note is that most CCD detectors are only efficient to about 1100 
nm wavelength as quantum efficiency drops considerably due to silicon absorption [6]. 
Furthermore, the high quantum efficiency (QE) of CCD detector, especially at the VIS-
excitation range, though enable weak Raman emissions to be detected, it also collect 
strong fluorescence signals arising from biological tissues which could be beyond the 
dynamic range of the CCD [22]. This fluorescence signal will also produce shot noise 
which may interfere with extraction of Raman information. Therefore, due to the 
limitation of current CCD detector technology, for biological tissue application, the 
optimal NIR excitation wavelength range is generally between 750 to 850 nm for 
collection of high quality Raman emission signals within a few seconds [6,22], with most 




A spectrograph is an important instrument that can separate an incoming light into 
different frequency on the CCD detector in real-time. For clinical application through 
using optical fiber and low-power laser excitation to collect incoming tissue scattered 
light into the spectrograph for CCD collection of spectral data with high spectral 
resolution of about 8-10 cm-1, careful selection of spectrograph would be necessary [22]. 
The employment of volume-phase transmissive dispersive grating spectrograph which 
has its f-number matched with the optical fiber could provide both the high throughout 
and flat image field at the detector plane required for sensitivity at low laser fluence and 
spectral resolution at the range of interest [22].  
 
In addition, an important factor which determines the sensitivity of a Raman spectrometer 
is the usable detection area (i.e., usable slit width x height) [45]. For the majority of 
Raman application, the larger the sampling area, the most scattered Raman signals can be 
gathered, which will increase the sensitivity of the Raman system [45]. On a multi-
channel detector dispersive-based spectrometer, a given spectral resolution often limits 
the slit width [45]. Extending the slit height using a straight slit usually causes the image 
to be curved on the detector due to optical effects [45]. If the optical effects are not 
corrected, the curved slit image will degrade the peak shape and spectral resolution. 45, 
46] One of the ways to correct this image distortion (i.e., aberration) effect is to use a 
curved entrance slit, opposite to the image curve distortion effect, so that a straight slit 
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 image can be achieved [46]. Most details will be provided in Chapter 3 on the corrected 
image aberration Raman spectroscopy system been utilized in this study.  
2.1.4 FIBER-OPTIC PROBE 
Medical applications usually require remote sampling use of optical fibers in which the 
sizes of the Raman probe and the fiber bundle are strictly limited by anatomic 
considerations [35]. For instance, in order to endoscopically evaluate stomach mucosa for 
gastric cancer with Raman spectroscopy, the size of the probe must be small enough (~2 
mm in diameter) and long enough (several meters) to be inserted into a narrow-diameter 
channel [35, 47]. Moreover, the design and material of the Raman probe must be able to 
undergo regular hospital instrument sterilization procedures [22].  
 
In addition to the physical demands which the Raman probe needs to face, there are also 
optical characteristic requirements which the Raman probe must possess in order to be 
clinically applied. For example, as the Raman probe can only probe a small tissue area of 
interest, it would require the guidance of different wide-field imaging modalities to the 
suspicious tissue area for evaluation [48]. Hence, the design of the fiber-optic Raman 
probe must be able to collect high S/N Raman signal in approximately 1s with safe levels 
of laser exposure for accurate clinical application of the spectral model used for analysis, 
while also minimizing the light interference from the use of the different wide-field 
imaging modalities [48]. On top of the external interference, the optical fiber also 
generated significant intrinsic spectral interference which must be greatly reduced [47]. 
Fiber fluorescence and absorption interference can be minimized through the use of high-
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 purity low-hydroxyl fibers, and Raman interference from the optical fibers can be 
removed through installing appropriate high performance filters at the distal tip of the 
probe [47]. However, the production of such Raman probe which demands high 
performance criteria, and yet requiring the size of the probe to be small (~2 mm) is of 
great technical challenge; hence, to date, only a few Raman endoscopic probe have been 
successfully developed [39, 45, 49, 50]. Note that one particular group has explored an 
alternative approach for designing the Raman probe such that the fabrication of such 
Raman probe is very much simpler. They have introduced the exploration of so-called 
“high-wavenumber” spectral range for tissue Raman diagnosis as this spectral range has 
minimal interference from the probe, thereby requiring less optical components in the 
design [51]. Hence, the use of “high-wavenumber” enable the use of a single, unfiltered 
optical fiber for guiding laser light to the sample and for collecting the back-scattered 
light to the spectrometer [51].This alternative approach is still an on-going area of 
research [51, 52] to unravel the potential which the “high-wavenumber” Raman 
spectroscopy could bring about for tissue diagnosis using Raman spectroscopy.  
2.2 AUTOFLUORESCENCE ELIMINATION APPROACHES TO ACHIEVE 
BACKGROUND-FREE RAMAN SPECTRUM 
Biological tissues under NIR excitation wavelength range of between 750 to 850 nm will 
not only collect weak Raman signals, but will also pick up intrinsic tissue 
autofluorescence emissions; thereby posing a significance challenge in recovering 
background-free Raman signals [47]. Through examining the dissimilarity in the inherent 
optical property of fluorescence and Raman emissions, various techniques have been 
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 attempted to recover Raman signals free from its concomitant autofluorescence 
background signal.  
2.2.1 TIME-GATING TECHNIQUES 
For instance, the lifetimes of fluorescence and Raman emissions are distinctly different: a 
fluorescence lifetime is roughly in the order of 10-9 to 10-7 second, while Raman 
scattering events are normally around 10-11 to 10-13s [53]. Hence, time-gating techniques 
such as Kerr-gating have been investigated as one of the potential method to separate 
Raman and fluorescence signals [6, 53]. As this technique aims to reject the fluorescence 
before it is detected, it can uniquely remove photon shot noise associated tissue 
autofluorescence signals. However, due to the need to use high excitation fluence pulsed 
lasers, on top of the high cost and complicated system design required, this technique is 
unsuitable for clinical application [54].  
2.2.2 SHIFTED EXCITATION RAMAN DIFFERENCE SPECTROSCOPY 
In addition, the shift response of the fluorescence and Raman effect to small excitation 
wavelength shifts allows another mechanism for removing the fluorescence background 
[55]: by Kasha’s rule which stated that majority of fluorescence is emitted from 
vibrationally relaxed states, small changes in excitation wavelength will have a minimal 
effect on the fluorescence emission; while, Raman emission will shift in energy by the 
amount of excitation shift [55]. Therefore, with two slightly different excitation 
wavelength (~5-10 cm-1) the fluorescence spectral profile would be invariant, while the 
entire Raman spectra will be shifted by the corresponding changes in excitation 
wavelength (~5-10 cm-1). The difference of the two emission spectral profile would 
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 eliminate the fluorescence background signal, leaving the difference Raman spectral. 
This difference Raman spectral is approximately the first derivatives of the original 
Raman spectrum, and hence reconstruction techniques such as integration or 
deconvolution would be able to retrieve the Raman spectrum without its concomitant 
autofluorescence background [6, 55]. This technique, commonly named “shifted 
excitation Raman difference spectroscopy” [6, 55, 56], is particularly attractive as it 
could enable the removal of large fluorescence background as well as other sources of 
random or systemic noise generated by, for example, the detector where the different 
sensitivity of individual pixels of the detector can produce systemic effects; thereby 
permitting sensitivity to true photon shot levels [57]. Hence, it has led to a new 
development of other modified technique such as the so-called “subtracted-shifted Raman 
spectroscopy”, which offers a more simplistic instrumental design by shifting the 
spectrometer grating (i.e., wavelength) instead of necessitating a tunable laser [57]. 
However, regardless of shifted excitation Raman difference spectroscopy or subtracted-
shifted Raman spectroscopy, this type of technique would be required to, at least, double 
the integration time in order to obtain the required spectra; which may not be clinically 
feasible if long integration time is required [54].  
2.2.3 FREQUENCY/WAVELENGTH-MODULATED  
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Since by Kasha’s rule which stated that fluorescence emission is independent of slight 
change in excitation wavelength, while Raman scattering frequency will change 
according to the amount of change in excitation wavelength, illumination of samples with 
frequency-modulated excitation light can also be used to remove fluorescence signal 
from Raman signal. This is done through modulating the excitation light at low 
 
 frequencies which will achieve time-invariant fluorescence signal [6, 54], and also yield 
Raman scattering frequencies which will shift with the modulated excitation light. Even 
though this technique is also an effective way to separate fluorescence and Raman 
signals, it requires the use of specialized instrumentation for modulation [54].  
2.2.4 DIGITAL POST PROCESSING 
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Most Raman signals appear as spike-like features residing on top of a broad band NIR 
autofluorescence background. Hence, mathematical post-processing techniques can be 
employed to separate the Raman and fluorescence signals [58]. By linearly transform the 
original data into another feature space such as carrying out Fourier-transformation on the 
NIR raw data, before introducing different filtering algorithms, can be applied for 
separation of the NIR Raman and background autofluorescence signal; however, this 
often lead to artifacts and distortions of the Raman spectrum, especially during a noisy 
situation [56]. One of the most efficient, easiest and accurate way to subtract the 
fluorescence signal with minimal distortion to the Raman signal is to fit the spectrum 
containing both Raman and fluorescence signals to a polynomial of a high enough order 
to describe the fluorescence line shape but not the higher frequency Raman line shape 
[6]. However, a single polynomial fitting for fluorescence background removal may not 
be sufficient to retain Raman signal with minimal fluorescence background interference 
[59]. Hence, improvement of the polynomial fitting algorithms has been investigated. For 
instance, an improved algorithm is such that all data points in the polynomial curve have 
an intensity value higher than the input spectrum (comprising of Raman and background 
autofluorescence signal) are automatically reassigned to the original intensity. This 
process will then re-run repeatedly until there is convergence in the number of data points 
 
 affected by each iteration, as determined by root test for convergence. The processed 
base-line spectrum is then subtracted from the original spectrum to achieve Raman signal 
with minimal autofluorescence background interference [59]. This algorithm works 
reasonable well but still suffers from a few weaknesses such as unable to take into 
account of noise interference, and divergence of the polynomial-fitting occurring at the 
endpoint of the selected spectral region of the tissue. Hence, new improved algorithms 
have been investigated to address these weaknesses for a more robust and unbiased 
removal of the tissue intrinsic autofluorescence background to achieve reliable Raman 
signals from biological tissue [60, 61]. Note that this is still an on-going active area of 
research [62, 63]. Overall, polynomial fitting provides the simplest (involves the simplest 
hardware configuration, and the simplest computational complexity among other 
methods) but relatively accurate method to extract Raman emissions with minimal 
autofluorescence background signal from biological tissues.  
Table 2.1 presents the Raman peak features which have been commonly found in the 
literature for biomedical studies, together with corresponding tentative biochemical 
assignments after removal of autofluorescence background with polynomial fitting. These 
multiple Raman biochemical features give rise to a “fingerprint spectrum” which can be 
very specific for tissue diagnosis, especially for precancer and cancer diagnosis [5]. The 
next section will provide a comprehensive literature review on Raman technique 






 Table 2.1 Raman peak features commonly found in the literature for biomedical studies 
with tentative biochemical assignments [1, 2, 5, 6, 7, 10, 15, 21, 29, 65] 
Peak position 
(cm )-1 Protein assignments Lipid assignments Others 
1745w  ν(C=O)  
1655vs ν(C=O) amide I (α-helix 
conformation, collagen)
  
1620w   ν (C=C) porphyrin
1585vw ν(C=C) olefinic   
    
1558vw ν(CN) and δ(NH) amide II  ν (C=C) porphyrin
1514   ν (C=C) carotenoid
1445vs δ(CH ), δ(CH ) 2 3 δ(CH ) scissoring2  
1379vw  δ(CH ) symmetric3  
1336mw (sh) δ (CH ), δ (CH ), twisting,
collagen
2 3   
1302vs δ(CH ) twisting, wagging, 
collagen
2 δ(CH ) twisting, wagging2  
1265s ν(CN) and δ(NH) amide 
III (α-helix conformation, 
collagen)
  
1208vw ν(C-C H ) phenylalanine6 5   
1168vw  ν(C=C), δ(COH) ν (C-C), carotenoid 
1122mw (sh)  νs(CC) skeletal  




1030mw (sh) ν(CC) skeletal, keratin   
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 1004mw ν(CC) phenylalanine ring   
973mw (sh) ρ(CH ), δ(CCH) olefinic3   
935mw ρ(CH ) terminal, proline, 
valine; ν(CC) α-helix 
keratin
3   
883mw ρ(CH )2   
855mw δ(CCH) phenylalanine, 
olefinic
 polysaccharide
ν, stretching mode; νs, symmetric stretch; νas, asymmetric stretch; δ, bending mode; ρ, 
rocking mode; v, very; s, strong; m, medium; w, weak; sh, shoulder 
 
2.3 REVIEW ON CANCER BIOLOGY 
Cancers mainly arise in epithelial tissue (~85%), which are the cells lining the surface of 
organs. Due to the constant exposure to carcinogens, they are likely to trigger a cascade 
of carcinogenesis events [65]. Most of these changes begin with early biochemical 
alterations, and a fraction of these diseased tissues will eventually progress to become 
malignant tumors [66]. At the cancerous stage, obvious morphological and tissue 
architecture changes can often be noticed and detected by the clinicians. However, the 
early lesions (e.g., early cancer and precancer), which can predispose to become invasive 
neoplasia, are often associated with subtle signs of tissue transformation that are difficult 
to identify by the clinicians [65]. Nevertheless, these precancerous and early cancer 





 It is important to recognize the various patho-histological features of neoplastic tissues 
which are generally distinct from normal tissues. For instance, malignant tumors are 
microscopically distinguished from the normal by cellular crowding and disorganization 
[6], nuclear content, nuclear-to-cytoplasmic ratio, mitotic activity, chromatin distribution, 
changes in the angiogenesis process and differentiation rate [60]. More specific well-
know characteristics of cancerous cells involve the production of a higher quantity of 
lactate acid for cancerous cells relative to the normal cells, changes in nuclear proteins 
that regulate cell division and DNA replications, activation of regulatory 
oncoproteins/oncogenes that results in repeated duplication and amplification of DNA 
sequences, and increase secretion of proteolytic enzymes such as serine, cysteine, and 
metalloproteinases [67]. One notes that the morphologic and biochemical changes that 
accompany neoplasia transformation are many and, most often depend on the specific 
type and location of the cancer [67]. For instance, alpha fetoprotein level is typically very 
low for adult human being. However, alpha fetoprotein has been found to increase 
significantly with the development of liver cancer, but not for other types of cancer such 
as carcinoma arising in the colon, lung, and pancreas [67]. In another instance, high 
molecular weight keratin, which is a unique feature of mature epithelium in the cervix, 
will be replaced by low molecular weight keratin during malignancy transformation; 
however, cancerous transformation involving all other keratinized tissues (e.g., buccal 
mucosa cancer) do not share this similar molecular alteration [6]. These confounding 
factors present a significant challenge for clinicians to detect different type of cancers at 
different organ sites. Nonetheless, cancerous transformation of tissue at different organ 
sites will result in changes in nucleic acid, protein, lipid, and carbohydrate 
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 conformational structures and compositions. Technology which can tap upon these 
biomolecular changes would be useful diagnostic tools for early detection of cancers.  
2.4 REVIEW ON RAMAN TECHNIQUE FOR PRECANCER AND CANCER DIAGNOSIS 
IN DIFFERENT ORGAN SITES 
This section will briefly provide an up-dated overview of the application of NIR Raman 
spectroscopic technique in precancer and cancer diagnosis for different organ parts.  
2.4.1 BLADDER CANCER 
Several studies have demonstrated the potential of Raman spectroscopy for bladder caner 
diagnosis [1, 33, 68, 69, 70]. For instance, Crow et al. demonstrated the feasibility of 
differentiation between benign (normal and inflammatory) and malignant tissues with a 
sensitivity and specificity of 90-95% and 95-98%, respectively [68]. They have also 
shown that NIR Raman spectroscopy could be used to stage bladder cancer into 
noninvasive and invasive malignant bladder tissues (i.e., transitional cell carcinoma) with 
an accuracy of 96% [68]. However, these proof-of-concept studies have been carried out 
with a free-space Raman system (i.e., Raman microscopy) testing on ex vivo bladder 
tissue samples. Hence, Crow et al. further verified that ex vivo bladder tumor can be 
discriminated from the ex vivo nontumor tissues with a NIR Raman spectroscopic system 
equipped with a fiber-optic probe which is compatible with the working channel of a 
flexible cystoscope [69]; thereby, suggesting the potential of NIR Raman spectroscopy 
which could be compatible with a conventional cystoscope for bladder cancer tissue 
diagnosis. Their group further utilized NIR Raman spectroscopy to determine the 
biochemical basis for different bladder pathologies which include high, moderate and low 
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 grades transitional cell carcinoma, carcinoma in situ (CIS), cystitis, and normal 
urothelium tissues [70]. These Raman studies provided an insightful understanding of the 
molecular changes in associated with bladder cancer, and also demonstrated the 
diagnostic utility of NIR Raman spectroscopy for detection of diseases occurring within 
the bladder.  
2.4.2 BRAIN CANCER 
Complete removal of malignant tissue, while preserving healthy tissue is a common aim 
of most oncosurgical procedures, particularly for brain surgery as imprecise targeting of 
brain tumors may increase the risk of damaging vital brain areas that may result in 
functional impairment (e.g. speech, movement and etc) [23]. On top of this, tissue 
samples obtained by stereotactic surgery are relatively small, sampling errors may easily 
occur which may miss crucial features essential for determining the follow-up procedures 
of brain cancer such as glioma, which is the most common type of brain cancer [23]. 
Hence, most of the Raman research in brain cancer area [52, 71, 72] has been aimed at 
the development of an in vivo Raman technique to assist stereotactic surgery for real-time 
intraoperative optical biopsy guidance, which to date, has not been realized. Recent ex 
vivo Raman works have also demonstrated the potential to detect and grade gliomas [71], 
and the feasibility of differentiation among glioma, meningioma and normal brain tissues 
[52]. These ex vivo results preliminary concluded that Raman spectra contain tissue 
molecular information which can be potentially employed for brain cancer detection.  
2.4.3 BREAST CANCER 
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Breast cancer is the most common cancer, and also the leading cause of cancer death in 
women worldwide [30]. This fatal disease has been extensively studied by many groups 
 
 to explore the feasibility of Raman spectroscopy to diagnose breast cancer [1, 30, 32, 34, 
41, 73, 74, 75]. For instance, Feld et al. have shown the potential of Raman spectroscopy 
for ex vivo tissue identification of infiltrating carcinoma, fibroadenoma, fibrocystic 
change, and normal breast tissue [32]. With the constructed diagnostic algorithm derived 
from their ex vivo tissue samples, they have also demonstrated the possibility of in vivo 
Raman spectroscopic cancer tissue identification during partial mastectomy breast 
surgery [30]. Recently, Stone et al. has also explored the potential of noninvasive Raman 
technology such as “spatially-offset Raman spectroscopy” and “transmissive Raman 
spectroscopy” techniques for noninvasive optical differentiation of different types of 
microcalcifications occurred during breast cancer [74, 75]. The detection of the different 
calcifications associated with breast cancer is important as it can be related to the 
metastasis state of breast cancer; however, to date, no reliable mean for assessing the type 
of microcalcification has been established [74, 75]. It is expected that Raman technology 
could also eventually provide a noninvasive diagnostic mean of assessing the tumor stage 
of malignant breast tissue.  
2.4.4 CERVICAL CANCER 
A decade of relentless effort by Mahadevan-Jansen et al. to pursue early detection of 
cervical cancer has passed [6, 17, 20, 65, 66, 76]. Their group has demonstrated their 
cervical precancers can be distinguished from benign tissue in vitro [17], as well as 
showing the possibility of Raman in vivo detection of cervical precancers [20] following 
their successful development of a fiber-optic probe for in vivo Raman measurements [77]. 
They have also constructed an organotypic tissue culture to further their understanding on 
cervical cancer development [78]. Recently, they have also shown the potential of Raman 
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 spectroscopy together with the use of sophisticated nonlinear multivariate statistical 
algorithms to detect metaplastic cervical tissues [66]. In addition, they have also further 
proved that hormonal variation will affect Raman readings and have robustly 
demonstrated that with the stratification of data by menopausal status, low grade 
dysplasia could be identified from normal with accuracy of nearly 100% [79]. In recent 
years, few other groups have also contributed to NIR Raman spectroscopic understanding 
on cervical cancer [80-82]. For instance, Jess et al. has demonstrated that Raman 
spectroscopy could be used to detect cervical cells infected with human papilloma virus 
(HPV) [80], and Vidyasagar et al. has shown that Raman spectroscopy could be used to 
predict radiotherapy response in cervix cancer [81]. Martinho et al. have also pointed out 
that the inflammatory infiltrates can affect Raman spectroscopic detection of low grade 
dysplasia [82]. The results of these various studies from different groups gradually bring 
NIR Raman spectroscopy closer to being employed for cervical precancer detection in a 
clinical setting.  
2.4.5 GASTROINTESTINAL CANCERS 
Shim et al. is the first to demonstrate that NIR Raman spectroscopy can be used to 
acquire reliable in vivo Raman signals in the entire digestive tract during clinical 
inspection [83]. To further robustly investigate the potential of Raman spectroscopy for 
detection of different gastrointestinal lesions related to cancer, various groups have 
performed laboratory-based Raman testings. For example, Kendall et al. has 
demonstrated sensitivities of 77-100%, and specificities of 92-100% for detection of 
metaplasia, dysplastic and cancerous lesions occurring in the esophagus with the use of 
Raman spectroscopy [13]. Boere et al. further verified the potential of NIR Raman 
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 spectroscopy to detect dysplasia occurring in the Barrett’s esophagus by using a rat 
model [84]. Ling et al. is the first to illustrate the potential of Raman spectroscopy for 
detection of gastric cancer [25], and Teh et al. further proved the possibility of NIR 
Raman spectroscopy to discriminate gastric dysplasia from normal tissues with diagnostic 
accuracy of 90% [12]. In addition, the feasibility of NIR Raman spectroscopy to detect 
precancers and cancers in the lower digestive tract (i.e., colon) has also been verified [1, 
9]. These studies demonstrated the diagnostic utility of NIR Raman spectroscopy for 
identification of different lesions associated with gastrointestinal cancers.   
2.4.6 HEAD AND NECK CANCER 
Raman spectroscopy has been shown to possess the potential to discriminate among 
normal, dysplastic and malignant changes in the epithelial cells of the larynx with 
diagnostic sensitivities of 83%, 76%, and 92%, and diagnostic specificities of 94%, 91%, 
and 90% [24]. Discrimination among normal, papilloma, and malignant laryngeal tissues 
with specificities of 86%, 94%, and 94%, and sensitivities of 89%, 69%, and 88% using 
NIR Raman spectroscopy has also been reported [21]. Additionally, successful 
differentiation of nasopharyngeal cancer from normal tissues (i.e., accuracy of 100%) 
with the use of NIR Raman spectroscopy has also been demonstrated [85]. Note that 
these works were in vitro studies, and in vivo study has yet to be demonstrated. 
Nevertheless, these investigations have shown that Raman spectroscopy possesses the 
potential as a tool to be used for improving efficacy in the detection of lesions occurring 
in the head and neck.  
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 2.4.7 LUNG CANCER 
Raman study (excitation wavelength at 647 nm) by Bakker Schut et al. investigated the 
level of carotenoids from lymphocytes of individual with and without cancer [86]. Their 
work indicated a considerable reduction of carotenoids in lung cancer patients compared 
with healthy individuals. Subsequent lung Raman investigations were carried out by both 
Yamazaki et al. [87] and Huang et al. [5] who have each reported on the feasibility of 
their in-house developed Raman spectroscopy system for ex vivo detection of lung cancer 
tissues [85]. Jess et al. further demonstrated that Raman spectroscopy could also be used 
for grading different malignant lung cells [88]. To further bring Raman technology closer 
to a clinical endoscopic application, Short et al. has successfully developed a fiber-optic 
Raman probe in vivo lung cancer detection [49]. However, they have reported 
overwhelming native autofluorescence signal from the bronchial tissues which obscured 
reliable Raman signals acquisition. Hence, they have explored the so-called “high-
wavenumber” spectral region to acquire lung tissue Raman signals and has preliminary 
demonstrated the feasibility of in vivo Raman spectroscopic lung cancer detection. 
Recently, Magee et al. has also developed a new Raman endoscopic probe and NIR 
Raman system based upon “shifted-subtracted Raman spectroscopy” to tackle the high 
autofluorescence background signals [89]. Their results indicated that their in-house 
developed Raman system based upon “shifted-subtracted Raman spectroscopy” technique 
could be effectively circumvent NIR autofluorescence background and acquire reliable 
tissue Raman data. They have also preliminary demonstrated the potential of their system 
to differentiate lung cancer from normal lung tissues. Hence, overall, regardless of “high-
wavenumber” Raman spectroscopy or “shifted-subtracted Raman spectroscopic 
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 technique” used in the fingerprint spectral region, Raman spectroscopy holds great 
promises as a useful diagnostic instrument for in vivo lung cancer detection.  
2.4.8 ORAL CANCER 
With a rat model, Bakker Schut et al. demonstrated the feasibility of a fiber-optic NIR 
Raman system for in vivo detection of dysplastic tissue occurring at the palate anatomical 
site with 100% accuracy [8].  Oliveira et al. further utilized an animal (i.e., hamster) 
model to cultivate dysplastic and cancerous oral lesions which were subsequently excised 
for ex vivo tissue Raman testings [90]. Their results suggested Raman spectra of 
dysplastic and cancerous oral tissues were very similar. Nevertheless, their group 
confirmed the diagnostic potential of Raman spectroscopy for oral cancer diagnosis. On 
top of the animal model Raman works, Krishna et al. validated the diagnostic potential of 
Raman spectroscopy using human ex vivo oral tissues to differentiate different 
pathologies associated with cancer [91, 92]. Their results indicated that Raman 
spectroscopy could be used to distinguish the cancer, inflammatory and normal tissues 
with 100% accuracy; thereby, providing more evidence that NIR Raman spectroscopy 
could be utilized for disease detection in the oral cavity.  
2.4.9 SKIN CANCER 
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Skin cancers including squamous cell carcinoma, melanoma and basal cell carcinoma, are 
among the cancers with the highest incidence worldwide [23, 35, 39]. These neoplastic 
lesions are often fatal if left undetected and untreated. Excisional biopsy currently 
remains the standard approach for cancer diagnosis, but is invasive, impractical, and 
could be unacceptable for screening high-risk patients who may have suspicious lesions 
localized in cosmetically important parts of the body such as the face [39]. The concept 
 
 of applying Raman spectroscopy for skin cancer diagnosis is particularly appealing as 
this optical spectroscopic technique is nondestructive and does not require any sample 
preparation, enabling acquisition of the spectra directly from the skin [23, 35, 39]. 
Gniadecka et al. provided the first Raman spectroscopic studies of skin cancer, in which 
they observed spectral differences between malignant and benign lesions such as the 
basal and squamous cell carcinoma vs. lentigo maligna, seborroic keratosis and nevus 
intrademalis [93]. Their group subsequently specifically demonstrated that melanoma 
could be discriminated from pigmented nevi, basal cell carcinoma, seborrheic keratoses, 
and normal skin with a sensitivity of 85% and specificity of 99% through the use of 
Raman spectroscopy in combination with artificial neural network. [94, 95] However, 
these studies were conducted through the use of FT-Raman, which could not be applied 
clinically. Nijssen et al. further demonstrated that basal cell carcinoma could be 
discriminated the perilesional skin with the use of a special fiber-optic Raman probe 
which explored the use of “high-wavenumber” Raman spectroscopy technique [96]. With 
the latest development of a portable optical fiber Raman microspectroscopy system 
which allows 40 μm measurement depth to be performed, Lieber et al. verified the 
potential of NIR Raman spectroscopy for tissue diagnosis of basal cell carcinoma and 
squamous cell carcinoma from normal and inflammatory skin tissues [97, 98]; they have 
achieved high diagnostic sensitivity of 91%, specificity of 95% for detecting the skin 
cancer lesions [97]. It should be also noted that Lieber et al. has observed that 
malignancy occurred at a deeper tissue layer (>40 μm) [97], however, Raman 
spectroscopy appeared to be able to detect malignancy-associated changes in the 
morphologically normal tissue surrounding the lesions. As a result, their group has 
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 further investigated the malignancy-associated changes for skin tissues with the use of 
organotypic raft culture, and further determined the possibility of Raman spectroscopy to 
detect malignancy-associated changes in the histologically-appearing normal tissue 
surrounding the lesions [65]. These works highlighted that Raman spectroscopy 
possesses the potential to elucidate biochemical changes closely related with diseased 
transformation, and could be employed as a unique diagnostic tool for clinical inspection.  
2.4.10 PROSTATE CANCER 
The prognosis and type of therapeutic intervention for prostate cancer is primarily based 
on clinical stage, serum prostate-specific antigen, and the Gleason score of the cancer 
[99].  The Gleason score grading is based on microscopic tumor architecture and the 
extent of the most prevalence pattern. As the tumor grades are indicator of intrinsic tumor 
behavior, characterizing the molecular phenotype of grade is of potential clinical 
importance [99]. As Raman spectroscopy is capable of optically probing the biomolecular 
changes associated with diseased transformation, it could be a potential instrument for 
detection and grading of prostate cancer. To date, Crow and Stone et al. has been the only 
group who has explored the possibility of NIR Raman spectroscopy for prostate cancer 
diagnosis [1, 100]. They have demonstrated the diagnostic efficacy of Raman 
spectroscopy to detect and grade prostate cancer in vitro with an overall accuracy of 89% 
[100]. Further investigation by their group has showed the feasibility of implementing 
NIR Raman spectroscopy with a fiber-optic probe for prostate cancer diagnosis [69]. In 
addition, they have investigated the biochemical basis for the spectral differences in 
correlation with benign prostatic hyperplasia, prostatitis, and three different grades of 
malignant prostate cancer [70]. Their results confirmed the molecular information which 
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 could be extracted by Raman spectroscopy for diagnosis of different prostate diseases. 
These studies provided a molecular basis towards clinical implementation of NIR Raman 
technology for possible noninvasive tissue diagnosis of prostate cancer in living patients.  
 
To summarize this chapter, the potential of NIR Raman spectroscopy for precancer and 
cancer diagnosis has been demonstrated in many different clinical fields such as the 
dermatology, gynaecology, gastrointestinal, neurology, respiratory, and urology [1,2,6-
9,12,13,15,16, 21,24, 73-100]. Even though Raman technique has progressively moved 
from in vitro tissue validation towards in vivo clinical trials due to substantial 
improvement in the hardware technology, further development of Raman equipment is 
still necessary, as the current state-of-the art instrumentation is not fully ready to be 
incorporate in the clinical practice yet [6, 15, 23, 35, 38, 39]. In addition, construction of 
a robust diagnostic algorithm which can robustly translate Raman spectral information 
into interpretable clinical information for real-time accurate tissue diagnosis still requires 
considerable development [23, 35, 39]. The following chapter will introduce on the 
different analytical techniques which could be implemented for Raman tissue diagnosis.  
2.5 ANALYTICAL TECHNIQUES FOR RAMAN CLASSIFICATION 
Raman spectroscopy can probe great wealth of biomolecular information ranging from 
nucleic acids, proteins, lipids and carbohydrates from biological tissues, and present the 
biochemical information on a Raman spectrum. However, the Raman spectrum usually 
contains many overlapping bands, and so data interpretation can not be easily made by 
simple visual inspection for subtle change in tissue pathology [22]. Hence, different 
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 statistical techniques would need to be implemented in order to made use of the 
biomolecular Raman signal for tissue analysis and classification.  
 
The Raman spectrum data usually consists of the results of observations of many 
different variables (i.e., Raman shift) for different cases (i.e., normal and diseased). Each 
of these variables could be considered to represent a different dimension. Hence, given n 
variables, each of the cases may be regarded to be located in a unique position in an n-
dimensional hyperspace, which is often very difficult to visualize. Therefore, various 
statistical algorithms have been explored to reduce this massive dimensional space to an 
interpretable dimensional space [36].  
 
Very often, tissue Raman spectra can be modeled using linear analysis as Raman 
spectrum of a mixture of biochemicals is approximately a linear superposition of the 
mixture’s component spectra, and the Raman signal intensity varies with the biochemical 
component concentration [22]. Thus, most of the dimensional reduction techniques which 
have been commonly explored for tissue Raman analysis are of the linear analysis 
methods [39]. The linear dimensional reduction techniques basically comprises of two 
types: unsupervised or supervised learning algorithms [22, 39]. The unsupervised 
learning algorithms aim to find intrinsic differences and similarities among the different 
cases, and group them into clusters. Well known examples of this approach are PCA, and 
hierarchical cluster analysis (HCA) [36]. In contrast, supervised pattern recognition 
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 methods utilize prior information on class memberships to construct a classifier using a 
portion of samples available (assigned as training set), and the rest will be used as test set 
to check the classifier performance. Examples of supervised techniques include LDA, 
and logistic regression (LR) [36]. In recent years, to further improve the diagnostic 
accuracies for tissue diagnosis using Raman spectroscopy, nonlinear learning algorithms 
such as support vector machines (SVM) [11], and artificial neural network (ANN) [94, 95] 
have also been explored. Below provides a short description of the different algorithms 
commonly applied for tissue diagnosis in Raman spectroscopy.  
2.5.1 PRINCIPAL COMPONENT ANALYSIS (PCA) 
Briefly, PCA decomposes the spectroscopic data matrix S into scores T and loading P, 
according to the relation,  
S  =  T. P     (2.1) 
 
With this equation, PCA transforms a number of correlated variables into a number of 
uncorrelated variables called principal components (PCs) which describe the greatest 
variance of the spectral data. It is usually employed as a method for variable or data 
reduction by retaining the first few principal components. In addition, inspecting the plots 
generated using scores provides a mean to assess the relationships between samples, 
since it helps to identify some clusters related to a certain feature and also for detecting 
potential outliers [39]. 
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 2.5.2 HIERARCHICAL CLUSTER ANALYSIS (HCA) 
In general, hierarchical cluster analysis is the partitioning of a dataset into clusters so that 
the differences between the data within each cluster are minimized and the differences 
between clusters are maximized according to a specific distance measure [36]. This is 
achieved through calculating the symmetric distance matrix (size n x n) between all 
considered spectra (number n) as a measure of their pairwise similarity/dissimilarity [39]. 
The algorithm searches for the minimum distance, collects the two most 
similar/dissimilar spectra into the first cluster, and recalculates spectral distances between 
all remaining spectra and the first cluster. In the subsequent step, the algorithm performs 
a new search to cluster more objects (spectra or already formed clusters) together. This 
searching and formation of clusters algorithm will be repeated n-1 times until all spectra 
have been merged into a single cluster. The final result will be displayed in a tree-like, 
two dimensional dendrogram in which one axis refers to the reduction of clusters with 
increasing number of iterations and the other axis to the respective spectral distances.  
2.5.3 LINEAR DISCRIMINANT ANALYSIS (LDA) 
LDA seeks linear combinations of the measurement variables which separate the objects 
from different classes as much as possible [101]. Factors which determine the 
separability of classes include the distances (e.g. Euclidean distances) between groups 
and the compactness of each group. It then follows that the ratio of the between-to-within 





 S max = {Variance between / Variance within)  (2.2) 
 
In other word, the aim of LDA is to find a discriminant function line that maximizes the 
variance in the data between groups and minimizes the variance between members of the 
same group [101]. Unknown object or specimen in our case can then be classified 
according to its position with respect to the discriminant function line [101].   
2.5.4 LOGISTIC REGRESSION (LR) 
The fundamental assumption of logistic regression is that the probability, pi, that the ith 
case in a set of spectral data belongs to a particular category, for instance, the data 
illustrating cancerous tissue will be described by the logistic function, which is of the 
form,  
pi = {1+ exp (α + ∑ βi xi )}-1   (2.3) 
 
with xi  the score associated with the ith basis spectrum, βi the corresponding weighting 
coefficient and α a constant offset [64]. This probability varies from zero to one with a 
sigmoid linkage function. It is small (i.e., zero) for large values of x and approaches to 
one for small values of x. The parameters β and α are often determined through maximum 
likelihood iterative technique, which aims to maximize the probabilities predicted for 
obtaining the specific calibration set [102].  
2.5.5 SUPPORT VECTOR MACHINES (SVM) 
SVM algorithm was firstly introduced by Vapnik [103]. It basically classifies two 
linearly separable set of data that belong to two different groups through the use of a 
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 hyperplane [104]. Although there are infinitely many hyperplanes that separate the two 
classes, SVM classifiers find the hyperplane that maximizes the distances between the 
two groups by solving a quadratic optimization equation, the Lagrangian dual problem, as 
shown below [104]:  
min w,b,ξ = (1/2) || w ||2 + (C/2) ∑ ξ2 
yi (<w.xi>+b) ≥ 1 – ξi, i=1,…..,n.   (2.4)  
  
Note that w represents the weights, ξ corresponds to a slack variable, b signifies the bias 
term, C denotes the penalty cost, x indicates the data set with n number of variables, and 
y illustrates the binary class information from the support vectors represented by the two 
integer, {-1, 1}. SVM can be extended to nonlinear classification by implicitly 
transforming the original data in a nonlinear space using kernel functions [104].  
2.5.6 ARTIFICIAL NEURAL NETWORK (ANN) 
ANN is another type of non-linear statistical data modeling tool which can be used to 
develop a classification algorithm [94]. One of the most popular and accurate ANN 
model is the multilayer perceptions based on the backpropagation algorithm [95] for 
training neural networks, which can be modeled as,  
y = f {b + ∑wi xi}     (2.5) 
  
with xi representing the variables, wi denoting the weighting coefficient,  b corresponding 
to a constant offset, f denoting a function, and y signifying the output. Backpropagation 
ANNs are constructed with a layered structure in which each node is connected to all 
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 nodes of the preceding and subsequent layer with different weights [95]. The input layer 
(variables) and the output layer (class membership) are generally connected by a single 
hidden layer. The input to each node is the linear combination of the outputs of the 
previous layer using the respective weights for the connections. Each node comprises of a 
Gaussian or sigmoid activation function. The output of the node is the result of the 
activation function for the input value, and the outputs will reveal the predicted class 
membership for the input cases [95].  
 
Overall, these different statistical algorithms have been commonly applied to construct 
diagnostic models for classification of different diseases with Raman spectroscopy. 
However, these different techniques could not sufficiently furnish the clinicians with 
physical meanings of diagnostic features derived for tissue characterization. Hence, the 
development of robust algorithms which can achieve a high predicted diagnostic 
accuracy and provide useful biomolecular diagnostic information from the high 
dimensional Raman spectral datasets will be clinically useful.  
2.5.7 RECURSIVE PARTITIONING TECHNIQUES 
Classification and Regression Tree (CART) is a form of recursive partitioning statistical 
technique that can selectively employ variables which are of utmost importance from a 
large number of input variables in databases for binary discrimination [105]. It is 
implemented by growing a tree structure with a root node containing all the objects, 
which are then further divided into nodes by recursive binary splitting. The theory of this 
technique has been robustly established by Leo Breiman et al. in 1984, and was originally 
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 meant to be utilized in mass spectroscopy analysis [105]. Following the next two decades, 
this algorithm has generated great attention in the scientific and clinical field due to the 
successful applications in numerous applications [106-110]. To further enhance the 
performance of CART, different variation of recursive partitioning techniques [111, 112] 
such as the random forests [113] have been successfully developed. Despite the 
usefulness of recursive partitioning algorithms in many different fields, including in the 
mass spectroscopy application, these algorithms have yet been reported in detail for 
Raman spectroscopic biomedical application in the literature.   
 
The following two chapters will present in details on the novel application of CART and 
random forests for Raman spectroscopic study on cancer diagnosis. The last three 
chapters will illustrate the commonly utilized analytic algorithms (i.e., empirical method 
(i.e., intensity ratio) and multivariate statistical techniques (i.e., PCA-LDA)) used for 
NIR Raman spectroscopy studies on different tissue/cell types for precancer diagnosis, 
and will also compare the diagnostic efficacy of these conventional Raman analytical 





  CHAPTER 3  
ASSESSMENT ON THE FEASIBILITY FOR USING A RAPID FIBER-
OPTIC NIR RAMAN SPECTROSCOPY SYSTEM TO CHARACTERIZE 
RAMAN PROPERTIES OF HUMAN TISSUE 
Despite the great advantages that NIR Raman spectroscopy could offer, there are 
technical challenges to overcome. For instance, achieving a high signal-to-noise (S/N) 
ratio while avoiding interference from silica Raman signals in a rapid manner can be 
difficult for in vivo tissue Raman measurements [12]. This is because tissue Raman 
scattering is inherently very weak, and the fiber-optic probes used to collect in vivo 
signals exhibit strong silica Raman scattering in the fingerprint region. Also, the 
integration times and irradiance powers for in vivo Raman measurements must be limited 
for practical and safety reasons [12, 47]. Therefore, the primary aim of this chapter was to 
investigate the use of a rapid in-house developed fiber-optic NIR Raman spectroscopy for 
characterization Raman properties of human mucosa tissues.  
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Figure 3.1 (a) Photograph of the in-house developed Raman system used to acquire 
tissue Raman measurements.  (b) Schematic of Raman spectroscopy system used for 
Raman collection. CCD: charge-coupled device; PC: personal computer.  
 
Figure 1(a) shows the instrument used for tissue Raman spectroscopic studies [12, 46]. 
Briefly, this system consists of a 785 nm diode laser, a transmissive imaging 
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 spectrograph with a Kaiser holographic grating, an NIR-optimized back-illuminated, 
deep-depletion CCD detector (Princeton Instruments, Trenton, NJ), and an unique fiber-
optic Raman probe. The 785 nm laser is coupled to a 200 μm core diameter fiber 
(NA=0.22) and the fiber is connected to the Raman probe via a subminiature version A 
(SMA) connector. The Raman probe was designed to maximize the collection of tissue 
Raman signals while reducing the interference of Rayleigh scattered light, fiber 
fluorescence and silica Raman signals (Figure 1(b)). One optical arm of the probe 
consists of a collimating lens, a bandpass filter (785 ± 2.5 nm, Chroma Technology 
Corp., VT) and a focusing lens to deliver the laser light onto the tissue. The other arm of 
the probe equipped with collimating and refocusing lenses and a holographic notch plus 
filter (optical density >6.0 at 785 nm; Kaiser) is used for collecting tissue Raman signals. 
The holographic notch filer was placed between the two lenses to block the Rayleigh 
scattered excitation laser light while passing the frequency-shifted tissue Raman signal. 
The refocusing lens then focused the filtered beam onto the circular end of the fiber 
bundle (58 x 100 μm core diameter fibers, NA = 0.22). Tissue Raman photons collected 
by the fiber bundle in the Raman probe are fed into the entrance of the transmissive 
spectrograph along a parabolic curve, and the holographic grating disperses the incoming 
light onto the liquid nitrogen-cooled CCD array detector controlled by a personal 
computer (PC) . The tissue Raman spectra associated with autofluorescence background 
are displayed on the computer screen in real time and can be saved for further analysis. 
The system acquired Raman spectra over the wavenumber range of 800-1800 cm-1, and 
each spectrum was acquired within 5 seconds with light irradiance of 1.56 W/cm2. The 
spectral resolution of the system is 4 cm-1.  
  42
 
 3.1.1 UNIQUE FEATURE OF THE IN-HOUSE DEVELOPED RAMAN SYSTEM 
All straight slit usually causes the image to be curved on the detector due to the 
diffraction effect: To understand this, consider the diffraction equation [45]: 
  mλ = d (sin α + sin β)     (3.1) 
where m is the diffraction order, λ is the wavelength, d is the groove spacing, and α  and 
β are the incident and diffraction angles respectively. This equation can only be applied 
to the light rays originating from a single point, which is the slit centre. After collimation 
of light before interacting with the grating groove, the light rays are perpendicular to the 
grating grooves, and are also parallel to the dispersion plane. Hence, the light rays 
originating from above or below the slit centre (i.e., a single point) will form a vertical 
out-of-plan off axis angle δ with the dispersion plane. The grating mimics a mirror with 
respect to the vertical angle δ and reflects light rays with the same vertical angle. As a 
result, the dispersion in the diffraction plane would be altered and will be represented by 
the below modified equation [45]:  
  mλ = d cos δ (sin α + sin β)     (3.2) 
As can be observed, it is the factor cos δ causes the curvature in the image plan. Briefly, 
the shape of the slit image is computed to be in the form of a parabolic curve  
  x’ = c’ y’2      (3.3) 
where  x’ and y’ are the distances in the x and y axis formed by the curved slit image in 
the image plan, and  c’ is a constant for a certain wavelength and is determined by the 
following [45]:   
c’ =  (mλ) / (2df2  cos β)  
    =  (sin α + sin β) / (2f2  cos β)   (3.4) 
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 where f2 is the focal distance from the focusing lens to the image plan. Note that the 
diffraction angle β’s dependence on δ is removed in equation (3.4) to illustrate the on-
axis condition where δ = 0. As a result, from the equation, it is obvious that the image on 
a straight slit in the shape of a parabolic curve. Four observations can be derived from 
this equation [45]. 
 
1. The curvature becomes more prominent as the diffraction angle increase. 
2. When m = 0, and β = - α, which will represent specular reflection, the curvature 
disappears. 
3. For opposite diffractions orders, their shapes are symmetric around the zeroth-
order reflection. 
4. The curvature becomes more prominent as the focal length f2 decreases. Hence, 
for compact spectrometers which usually utilize short focal distance lenses, the 
curvature is very much obvious. However, short lenses are necessary because of 
the high numerical aperture it provides (or low f/number). 
 
Therefore, in order to obtain a straight slit image, a curve entrance opposite to the curved 
slit image can be employed. Using symmetry, the shape of the entrance slit is also a 
parabolic curve and is described by [45]:  
x = cy2       (3.5) 
c    =  (sin α + sin β) / (2f1  cos β)   (3.6) 
where  x and y are the distances in the x and y axis in the entrance slit, and where f1 is the 
focal distance from the entrance slit to the collimating lens. Note that the shape of the 
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 parabolic curve at the entrance slit needs to be accounted for the magnification lens used 
in the spectrometer. 
 
For ease of manufacturing, an arc to approximate the parabolic curve can be carried out. 
Hence, solving the below equation will yield the radius of the arc (R) [45, 46].  
R    =  1/2c      (3.7) 
Since the ideal radius of the arc is dependent on wavelength, only one wavelength can be 
fully corrected, and residual curvature will exist for all other wavelengths. For the Raman 
system employed in this dissertation, spectrograph image aberration was corrected by a 
parabolic-line fiber array, permitting complete CCD vertical binning, thereby yielding a 
3.3-16 fold improvement in S/N ratio for the use of 785 nm excitation rays [12, 46]. To 
date, this is the unique design to correct for image aberration effect for Raman 
spectroscopic study in the literature. The greatly enhanced S/N ratio allows rapid 
acquisition of weak Raman signals from biological tissues within 1 sec [46].  
3.2 DATA PREPROCESSING 
Due to the gradual change in quantum efficiency of the CCD detector across the NIR 
spectral range which affects the instrument sensitivity with increasing wavelength, 
etaloning in the CCD, and variation in the individual CCD pixel sensitivity, this can 
result in a rapid oscillation in the sensitivity of a Raman instrument with changing 
wavelength [1]. Hence, in order to extract reliable data independent of these inherent 
effects from the Raman system, all wavelength-calibrated spectra were corrected for the 
wavelength-dependence (system response) of the system using a standard lamp (RS-10, 
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 EG&G Gamma Scientific, San Diego, CA). Figure 3 shows an example of a tissue raw 
spectrum before and after correcting for the system response.  
 


































Figure 3.2 Example of a tissue raw spectrum (a) before and (b) after correcting for the 
system response. 
 
The raw spectra acquired from gastric tissue in the 800-1800 cm-1 range represented a 
combination of prominent tissue autofluorescence, weak tissue Raman scattering signals, 
and noise [12]. Thus, the raw spectra were preprocessed by a first-order Savitsky-Golay 
filter (window width of 3 pixels, which corresponded to the system spectral resolution) to 
reduce noise (Figure 3(a)) [114]. A fifth-order polynomial was found to be optimal for 
fitting the broad autofluorescence background in the noise-smoothed spectrum (Figure 
3(b)), and this polynomial was then subtracted from the raw spectrum to yield the tissue 
Raman spectrum alone (Figure 3(c)) [12]. 
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Raman Shift (cm-1)  
Figure 3.3 Example of a tissue raw spectrum (a) after noise removal via Savitsky-Golay 
filter, (b) followed by fitting the autofluorescence background with a 5th order 
polynomial, and (c) this polynomial was then subtracted from the raw spectrum to yield 
the tissue Raman spectrum alone. Note: tissue raw spectrum and tissue Raman spectrum, 
black; 5th order polynomial autofluorescence background, red.  
 
In order to achieve tissue Raman data independent of Raman spectroscopic measurement 
conditions such as excitation/detection geometries, excitation light power fluctuations, 
probe-tissue positioning variations, different tissue sample size, and etc, each of 
background-subtracted Raman spectra was also normalized to the integrated area under 
the curve from 800-1800 cm-1 to enable a better comparison of the spectral shapes and 
relative peak intensities among the different tissue samples [5, 16].  
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 3.3 EX VIVO TISSUE SAMPLES  
In this study, a total of 146 gastric tissue samples were collected from 70 patients who 
underwent resection or endoscopic biopsies with clinically suspicious lesions. All 
patients preoperatively signed an informed consent permitting the investigative use of the 
tissues, and this study was approved by the Ethics Committee of the National Healthcare 
Group (NHG) of Singapore. After biopsies or surgical resections, tissue samples were 
immediately sent to the laboratory for Raman measurements. After spectral 
measurements, the tissue samples were fixed in 10% formalin solution and then 
submitted back to the hospital for histopathologic examination. The tissue specimens 
comprised five histological groups: normal gastric tissue, dysplastic gastric tissue, 
cancerous gastric tissue, normal laryngeal tissue, and cancerous laryngeal tissue. Table 
3.1 lists the number of samples associated with each of the histological type of gastric 
and laryngeal tissues. Note that the tissue samples were typically approximately 3 ×  3 ×2 
mm in size, and the incident laser light with a beam size of 1 mm was focused on the 
tissue mucosal surface to mimic the in vivo clinical measurements.  
Table 3.1 Type and number of human tissues collected.  
Type of tissue Histology type Number of samples 
Gastric Normal 55 
 Dysplasia 21 
 Cancer 18 
Laryngeal Normal 20 
 Cancer 30 
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 3.4 RAMAN MEASUREMENTS  
To assess intra-sample variability, multiple Raman measurements (n=5) on each of the 
tissue were made at different locations of the same samples. Figure 3.4 shows an example 
of the mean normalized Raman spectrum ± 1 standard deviation (SD) measured from a 
normal gastric tissue, illustrating spectral intensities variation of 30% about the mean for 
normal tissue. Overall, the relative Raman peak heights, shapes and positions showed 
little intra-sample variability for all gastric and laryngeal tissues, indicating the relative 
homogeneity of tissue samples used in this study [12].  































Figure 3.4 Mean normalized gastric Raman spectra (solid line) ± 1 standard deviation 
(SD) (gray area) obtained from a normal by multiple measurements (n=5) at various 
locations for each sample. Each spectrum was normalized to the integrated area under the 
curve to correct for variations in absolute spectral intensity. All spectra were acquired in 
5 seconds with 785 nm excitation and corrected for spectral response of the system. 
 
Figure. 3.5 shows the mean normalized Raman spectra ± 1 SD of the different types of 
gastric and laryngeal tissue. Table 3.2 further lists the tentative biochemical assignments 
for the 8 major Raman vibrational bands consistently observed in all different tissue types 
[10, 12]. As can be observed in Figure 3.5, the Raman spectral pattern between the 
different tissue types (i.e. normal gastric, dysplasia gastric, cancerous gastric, normal 
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 laryngeal, cancerous laryngeal) could be very similar, and there are significant inter-
sample variability which may obscure the inter-pathology variability. Hence, it is highly 
desirable to develop robust diagnostic approaches to extract all possible diagnostic 
information contained in tissue Raman spectra for well correlation with the different 
tissue types.  















































Figure 3.5 Mean Raman spectra ± 1 SD of normal gastric tissues (n=55), dysplastic 
gastric tissues (n=21), cancerous gastric tissues (n=18), normal laryngeal tissues (n=20), 




Table 3.2 Tentative assignments of the major Raman peaks identified in gastric and 
laryngeal tissues [10, 12].  
Raman wavenumber (cm-1) Tentative biochemical assignment 
875 ν (C-C) of hydroxyproline 
1004 ν s(C-C) ring breathing of phenylalanine 
1100 ν (C-C) of phospholipids 
1208 ν (C-C6H5) of tryptophan and phenylalanine 
1335 CH3CH2 wagging mode of nucleic acids 
1450 δ (CH2) of proteins 
1655 ν (C=O) of amide I, α-helix of proteins 
1745 ν (C=O) of phospholipids 
Note: ν, stretching mode; δ, bending mode 
In conclusion, an in-house developed NIR Raman system (Section 3.1) coupled with 
effective pre-processing techniques (Section 3.2) could be efficiency used to acquire 





 CHAPTER 4  
NOVEL DIAGNOSTIC ALGORITHM FOR RAMAN TISSUE 
CLASSIFICATION:  RECURSIVE PARTITIONING TECHNIQUE – 
CLASSIFICATION AND REGRESSION TREES (CART) FOR GASTRIC 
CANCER DIAGNOSIS 
Despite a falling incidence rate of gastric cancer, it is still the fourth most common 
malignancy and also the second leading cause of cancer deaths in humans, accounting for 
600 000 deaths worldwide [115, 116]. If the tumor is detected early and treated before it 
has invaded the gastric wall, the survival rate of the patient will increase tremendously 
[116]. However, early identification and demarcation of such lesions in the stomach can 
be very difficult to detect by the conventional diagnostic method-white-light endoscope 
which heavily relies on the visual observation of gross morphological changes of tissue, 
leading to a poor diagnostic accuracy. Excisional biopsy currently remains the standard 
approach for cancer diagnosis, but is invasive and impractical for screening high-risk 
patients who may have multiple suspicious lesions. 
 
Raman spectroscopy which makes use of inelastic light scattering process to capture 
“fingerprints” of specific molecular structures and conformations of a given tissue or 
disease state, has shown to be a promising optical diagnostic technique for identifying 
malignant tissues in various organ [5, 13-15, 25-28]. In order to convert molecular 
differences subtly reflected in Raman spectra between different tissues types into 
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 valuable diagnostic information for clinicians, multivariate statistical techniques have 
been successfully deployed in developing effective diagnostic algorithms for Raman 
spectroscopic diagnosis of cancers [1,2,6-9]. Due to the complexities of the biological 
tissues, PCA, which is able to take into account of the whole range of Raman spectral 
features of the tissue, has often been applied to simplify the computational complexities 
for the development of effective classifier algorithms (e.g., LDA, LR) without 
compromising diagnostic accuracy [1, 7, 13, 30, 34]. However, PCA does not necessary 
provide the physical meanings of component spectra for tissue classification [29]. Very 
recently, the classification and regression tree (CART) technique, which bases on the 
recursive partitioning for generating discriminatory algorithms and possesses potential to 
uncover interactions among prognostic factors in complex dataset, has received extensive 
attention in biomedical fields, such as proteomics, genomics and mass spectroscopy [105-
110]. For instance, John et al. applied both neural network and CART on liver cancer 
proteomes and found that both algorithms produced equally good predictive ability [106]. 
Garzotto et al. employed CART to identify prostate cancer from normal tissue with the 
sensitivity of 96.6% [107]. Zhang et al. also made use of CART on mass spectral urine 
profiles to achieve the sensitivity of 93.3% and specificity of 87.0% for separating 
transitional cell carcinoma of from normal bladder tissue [108]. Despite these successful 
applications, to date, CART technique has yet been applied to Raman spectroscopy for 
elucidation of Raman spectra in tissue diagnosis. In this chapter, we explore the 
feasibility of applying the CART technique to develop effective diagnostic algorithms for 
differentiation of near-infrared (NIR) Raman spectra between normal and cancer tissue, 
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 and to further understanding of molecular changes reflected in Raman spectra of tissue 
associated with the onset of malignancy in the stomach [14].  
4.1 THEORY OF CLASSIFICATION AND REGRESSION TREES  
Classification and Regression Tree (CART) is a statistical technique that can selectively 
employ variables which are of utmost importance from a large number of input variables 
in databases for binary discrimination [105]. It is implemented by growing a tree 
structure with a root node containing all the objects, which are then further divided into 
nodes by recursive binary splitting. The split which gives the best reduction in impurity 
between the mother group (tp) and the daughter groups (tl and tr) at different nodes of the 
tree is sequentially selected in the construction of CART tree. The maximization of 
change of impurity function20, ∆ i(t), at each node, is defined as: 









,                (4.1) 
where xj represents different variables for different values of j from a total of M variables; 
xjR represents the best splitting value of xj; i(tp), i(tl) and i(tr) are the impurity functions 
belonging to the parent node tp, left child node tl, and right child node tr of the parent 
node, respectively. Pl and Pr are the probabilities of achieving left and right nodes, 
respectively. CART will search through all possible values of variables for the best 
splitter at the maximal ∆ i(t) (xj < xjR). In this study, Gini index is used to determine the 
impurity, i(t), at each node which forms the criterion for splitting [105]. 














,                             (4.2) 
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 where c is the number of different classes, n is the total number of objects and nj is the 
number of objects from class j present in the node. Generally, a tree is firstly grown to its 
maximal size until the terminal nodes are sufficiently small. However, the maximum size 
tree that is usually overfitted with noise could not generalize well for future dataset. 
Henceforth, the tree is usually gradually shrunk by pruning away terminal nodes that lead 
to the smallest decrease in accuracy [67]. For each subtree Т, a complexity-
misclassification cost function, Rα(Т), is generated: 
Rα(Т) = R(Т) + α |Т|,      (4.3) 
where R(Т) is the resubstitution misclassification error of T; |Т| and α represent the 
number of terminal nodes and the cost of complexity per terminal node, respectively. 
During each successive pruning process which resulted in a smaller subtree (the subtree 
T’ ≤ T that minimizes Rα(T’)) with a smaller number of terminal nodes, α will gradually 
increase. As a result, searching for an optimal tree size (defined with respect to expected 
performance on the cross-validated dataset) is equivalent to finding the correct α so that 
the information in the learning dataset is best fit rather than overfit or underfit [105].  
 
Although only one variable would be selected as the best splitter at any node in a CART 
tree, there would always be a second best variable which may perform nearly as good as 
the best splitter. These second best variable(s) could be masked by the best splitter(s) and 
would not appear in the final CART tree. As such, to avoid masking the importance of 
any variables used in CART, the relative importance of each input variable is assessed 
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 based on its importance over all possible nodes and splits by “variable ranking method” 
[67]. Using the variable ranking method, the importance of a variable Xm is defined as: 




Δ ,        (4.4) 
with IΔ ),~( tsm = max , which equals the maximal decrease in node impurity 
for the division of a parent node t into daughter nodes C
1C
IΔ ),( tsm
1 and C2 guided by a surrogate 
split ms~ . A surrogate split is defined by a surrogate variable. This variable is the second 
best variable, following the selected variable and giving the second best reduction in 
impurity of the mother group into the daughter groups. This maximal decrease in node 
impurity is summed for all the nodes of the optimal subtree, T, to obtain the importance 
of a variable. 
 
In this study, a 10-fold cross-validation was chosen to select the optimal tree size [14]. 
The learning dataset is randomly divided into 10 subsets. One of the subsets is used as 
independent testing dataset, while the other 9 subsets are combined and used as training 
dataset. The tree growing and pruning procedure is repeated 10 times, each time with a 
different subset as testing dataset. For each tree size, the resubstitution and cross-
validation error are calculated, averaged over all subsets. The misclassification cost 
obtained for each subtrees on the cross-validation subset is matched with the subtrees of 
the complete model learning dataset using the α values. The optimal sized tree is 
proposed to be the tree within one standard error (SE) of the complexity-misclassification 
rate for the tree with the minimum complexity-misclassification rate [105]. 
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 4.2 DEVELOPMENT OF CART DIAGNOSTIC ALGORITHM FOR RAMAN GASTRIC 
CANCER DETECTION  
4.2.1 TISSUE RAMAN DATASET  
Figure 4.1 shows the mean Raman spectra of normal (n=115) and cancer (n=61) gastric 
tissue in the model learning dataset. 9 prominent Raman peaks were observed in both 
normal and cancer tissue at the following locations with its respective tentative 
biochemical bond assignment: ~875 cm-1, C-C stretching modes of proteins; ~1004 cm-1, 
C-C6H5 symmetric ring breathing of phenylalanine; ~1100 cm-1, C-C stretching of 
phospholipids; ~1230 cm-1, C-N stretching and N-H bending modes of amide III of 
proteins; ~1265 cm-1, C-N stretching and N-H bending modes of amide III of proteins; 
~1335 cm-1, CH3CH2 twisting of proteins and nucleic acids; ~1450 cm-1, CH2 bending of 
proteins and lipids; ~1655 cm-1, C=O stretching of amide I of proteins; ~1745 cm-1, C=O 
stretching of phospholipids [14]. The gastric cancer tissues showed higher intensities at 
1265, 1450, and 1655 cm-1, while lower at 875, 1004, 1100 and 1745 cm-1, compared to 
normal tissues. Besides the intensity differences, there are also significant differences in 
Raman spectral shapes between normal and cancer tissues, which includes broadening of 
Raman bandwidths at around 1450 and 1655 cm-1, and red shifting of Raman peak at 
1655 cm-1 for gastric cancer tissues, confirming the potential role of Raman spectroscopy 




Figure 4.1 Mean Raman spectra of gastric tissues from (a) normal (n=115) and (b) 
cancer (n=61) in learning Raman dataset. 
 
Table 4.1 lists the mean and SD values of 7 prominent Raman peaks that are 
diagnostically significant (unpaired two-sided Student’s t-test, p <0.05) for tissue 
classification, demonstrating significant overlappings of intensities between gastric 
normal and cancer tissue. Using each of these individual Raman intensities for diagnosis, 
the overall sensitivity and specificity varied by 60% – 82% and 60% – 75%, respectively. 
To further improve tissue classification, CART was subsequently employed to correlate 
all the diagnostically significant Raman peak intensities with tissue pathologies. 
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 Table 4.1 Statistical characteristics of diagnostically significant Raman peaks (unpaired 











875 0.011 (0.002) 0.009 (0.003) 70.5 (43/61) 74.8 (86/115) 0.0000011 
1004 0.011 (0.002) 0.010 (0.002) 62.3 (38/61) 66.1 (76/115) 0.0075823 
1100 0.011 (0.002) 0.008 (0.002) 68.9 (42/61) 73.9 (85/115) 0.0000184 
  1265* 0.003 (0.002) 0.005 (0.002) 65.6 (40/61) 65.2 (75/115) 0.0000002 
  1450* 0.011 (0.003) 0.013 (0.003) 82.0 (50/61) 60.0 (69/115) 0.0000016 
  1655* 0.007 (0.002) 0.008 (0.002) 70.5 (43/61) 61.7 (71/115) 0.0000019 
1745 0.005 (0.003) 0.004 (0.003) 60.7 (37/61) 61.7 (71/115) 0.0000061 
Note:  
SD: standard deviation 
The symbol * denotes a particular Raman peak intensity with cancer tissue being higher 
than normal tissue 
 
4.2.2 CART APPLICATION TO THE TISSUE RAMAN DATASET 
Figure 4.2 (a, b) shows the relationship of complexity with respect to the 
misclassification cost and the number of terminal nodes for both cross-validated and 
resubstitution error after 10-fold cross-validation of the model learning dataset. The 
misclassification cost for the resubstitution error increases monotonically as the 
complexity increases with a corresponding decrease in terminal nodes. On the other hand, 
the misclassification cost for the cross-validated error increases at a slower rate compared 
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 to the resubstitution error. A local minimum misclassification cost of 0.1875 is found at 
complexity of 0.00568 for the cross-validated error. Consequently, the optimal sized tree, 
defined according to the cross-validated dataset, was chosen to be at complexity of 
0.00852 with 13 terminal nodes that is within one SE of the complexity-misclassification 
cost of the local minimum complexity-misclassification cost.  
 
Figure 4.2 Dependence of complexity,α, on (a) misclassification cost nodes for cross-
validated error after 10-fold cross-validation, and resubstitution error, and on (b) number 
of terminal nodes for resubstitution error of the CART model learning dataset. The 
optimal sized tree was chosen to be at complexity of 0.00852 with 13 terminal nodes 





 Figure 4.3 displays the CART analysis procedure in a classification model based on the 
model learning dataset (80% of total dataset). With the CART model, 6 diagnostically 
significant Raman peaks at 875, 1100, 1265, 1450, 1655, and 1745 cm-1 are inter-linked 
differently to build the following 13 subgroups (designated as either normal or cancer in 
the terminal subgroups): normal - Group 1, Group 3, Group 6, Group 7, Group 9, Group 
11, Group 13; cancer - Group 2, Group 4, Group 5, Group 8, Group 10, Group 12. All 
these 6 significant Raman peak intensities are combined differently to build the 7 normal 
and 6 cancer subgroups for best tissue classification.  
 
Figure 4.3 The optimal classification tree generated by CART method after 10-fold 
cross-validation of the model learning dataset by utilizing 6 significant Raman peaks 
(875, 1100, 1265, 1450, 1655, and 1745 cm-1). The binary classification tree composed of 
12 classifiers and 13 terminal subgroups. The decision making process involves the 
evaluation of if-then rules of each node from top to bottom, which eventually reaches a 




Table 4.2 tabulates the variable ranking of the Raman peaks and the total number of 
appearing times of different intensity features to generate the CART-based diagnostic 
model (Fig. 4.3). According to the variable ranking method, the most and least important 
Raman peaks are found to be located at 875 and 1004 cm-1, respectively. By assessing the 
final CART-based diagnostic model, the Raman peaks which appeared the most and least 
number of times are located at 1745 and 1004 cm-1, respectively. For Raman peaks 
located at 1655, 1265, 1100 and 1450 cm-1, in the order of descending variable rankings, 
appeared 2, 2, 1 and 2 times, respectively, in the final CART model. As a result, Raman 
peaks at 875, 1100, 1265, 1450, 1655, and 1745 cm-1 are found to be most constructive 
towards building the final CART-based diagnostic model, with Raman peaks at 875 and 
1745 cm-1 as the most important variables for tissue classification.  
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 Table 4.2 The variable rankings of all the input Raman peak intensity features (n=7) 
computed by the CART algorithm, with the corresponding total number of times of the 
respective feature appearing in the final CART-based diagnostic model. 
Raman peak 
(cm-1) 
Number of times appearing in the final 
CART model 
# Variable Ranking 
(Importance) 
875 2 1 
1004 0 7 
1100 1 5 
1265 2 4 
1450 2 6 
1655 2 3 
1745 3 2 
Note:  
The symbol # denotes a particular Raman peak intensity with variable rankings (1 as the 
most importance and ranking 7 as the least importance). 
 
4.2.3 EVALUATION OF THE CART ALGORITHM WITH PROSPECTIVE STUDY 
To evaluate the performance of the CART-based diagnostic algorithms for predicting the 
prospective cases (generalization), a randomly selected validation dataset (20% of total 
dataset) was used in which 6 important Raman peaks (875, 1100, 1265, 1450, 1655, and 
1745 cm-1) were utilized as an input in the final CART-based diagnostic model. Table 4.3 
summarizes the classification results of the 2 pathologic groups (normal vs. cancer) for 
both the model learning dataset (after 10-fold cross-validation) (80% of total dataset), and 
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 the validation dataset (20% of total dataset). The sensitivity of 90.2% and specificity of 
95.7% can be obtained for the model learning dataset, while a predictive sensitivity and 
specificity of 88.9% and 92.9% can be achieved for the independent validation dataset. 
The results show that CART-based diagnostic algorithms that utilize the most 
diagnostically important peaks of Raman spectra are powerful and robust for accurately 
predicting the tissue types in the prospective new cases. 
Table 4.3 Classification results of Raman prediction of the 2 pathological groups with the 
model learning dataset (80% of total dataset) using the 10-fold cross-validation method, 
and the validation dataset (20% of total dataset) using a CART-based diagnostic 
algorithm. 
Raman prediction 
Pathology and Classification 
Normal Cancer 
Total 
Learning model Normal 110 5 115 
Cancer 6 55 61 
Sensitivity (%) 90.2 
(after 10-fold 
cross validation) 
Specificity (%) 95.7 
 
 
Testing model Normal 26 2 28 
Cancer 2 16 18 
Sensitivity (%) 88.9  




 Applying CART technique for classification of tissue Raman spectra, the high predictive 
diagnostic sensitivity and specificity can be achieved for the independent validation 
dataset (Table 4.3). Further model validation analysis via 5-fold cross validation reveals 
that the cross validated result is almost similar to the independent validation dataset 
classification results and the PCA-LDA approach (PCA-LDA is slightly higher compared 
to CART) (data not shown) [105]. These further reinforced that the CART-based 
diagnostic algorithms generated are robust and powerful for tissue diagnosis and 
characterization by Raman spectroscopy. Besides the ability for tissue classification, 
CART diagnostic model could also provide a novel way for better understanding of the 
relationship between the disease-related biochemical changes of Raman spectra and 
tissue pathologies. We use the CART technique to evaluate how different Raman 
molecular information are correlated with tissue types by analyzing how the different 
Raman peaks are inter-linked to optimally form different subgroups for tissue 
classification. For instance, in Figure 4.3, it is found that Group 5 (cancer subgroup) has 
the highest probability of incidence, followed by Group 3 which is a normal subgroup for 
both the model learning and validation datasets. In Group 5, CART indicates that cancer 
gastric tissues are associated with a relative increase in Raman peak intensities at 1655 
and 1745 cm-1, while a decrease at 875 and 1450 cm-1. These results are in fact in 
agreement with the reports on the decrease of Raman intensity ratio at 1655 cm-1 to 1455 
cm-1 associated with malignancies in the cervix and lung [5, 20]. CART also notes that 
the Raman peaks at 875 and 1745 cm-1 representing collagen and phospholipids, 
respectively, appear to be significantly correlated with the Raman peaks at 1450 and 1655 
cm-1 for identifying the cancer subgroup (Group 5). Conversely, the Raman peaks at 875, 
  65
 
 1655 and 1745 cm-1 utilized to construct cancer subgroup (Group 5) could be employed 
for identifying the normal subgroup (Group 3). CART also indicates that compared to 
cancer tissue, normal gastric tissues tend to be related with high collagen contents 
(Raman peak at 875 cm-1) in extracellular matrix, high lipid contents (Raman peak at 
1745 cm-1) present in both extracellular matrix and cytoplasm, and a lower histones 
content (Raman peak at 1655 cm-1) in the nucleus. Further investigation on other 
subgroups shows that heterogeneous molecular changes may occur in tissue, enabling 
cancer subgroups to be distinguished from normal. For example, the collagen content 
typically decreases with malignancy, but there are quite a number of other cancer 
subgroups (Group 2, Group 8 and Group 10) to be associated with increase in collagen 
content. These subgroups are accompanied by either less phospholipids or higher histones 
content which could enable them to be distinguished from normal tissue. The above 
CART-Raman analysis results indicate that most biochemical/biomolecular information 
from tissue and cells are essential for tissue discrimination, and the CART-based 
diagnostic model is able to partition different subgroups based on different compositions 
of Raman molecular information for separating gastric cancer from normal. Therefore, 
the CART-Raman algorithm may provide new insights into the biochemical/biomolecular 
changes associated with malignant transformation [12]. 
 
In summary, the CART technique was first introduced and implemented to develop 
effective diagnostic algorithms for classification of Raman spectra between normal and 
cancer gastric tissues. This work shows that NIR Raman spectroscopy in combination 
with powerful CART algorithms has potential to provide an effective and accurate 
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 diagnostic means for cancer diagnosis in the gastric. Further studies to investigate the use 
of a more powerful diagnostic algorithm which is primarily based on the recursive 
partitioning technique has also been carried out and will be elaborated more in details in 
the next chapter. 
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 CHAPTER 5  
IMPROVED RECURSIVE PARTITIONING TECHNIQUE FOR RAMAN 
TISSUE DIAGNOSIS: AN ENSEMBLE APPROACH – RANDOM 
FORESTS FOR IDENTIFICATION OF LARYNGEAL MALIGNANCY 
Laryngeal squamous cell carcinoma is one of the most common malignancies in the head 
and neck and also the sixth most common malignancies worldwide [117, 118]. In 
Southeast Asia, the rates of incidence and mortality due to laryngeal cancer are notably 
higher than many parts of the world [119]. Early identification and accurate demarcation 
of such malignant lesions coupled with effective therapy (particularly for partial 
laryngectomy, transoral excision, photodynamic therapy and radiotherapy) are crucial to 
improving the survival rates of the patients [118, 120]. However, identification of early 
malignancy in the larynx can be very challenging even for the very experienced 
otolaryngologists with the aid of conventional diagnostic techniques such as white-light 
endoscope (e.g. microlaryngoscopy, transnasal esophagoscopy); since the white-light 
endoscopy heavily relies on the visual observation of gross morphological changes of 
pathologic tissues, leading to a poor diagnostic accuracy. This limitation poses a great 
challenge in an ear-nose-throat (ENT) clinic and, therefore, there is of significant clinical 
values for the development of new endoscopic diagnostic techniques to complement 
white-light endoscopy for improving diagnostic performance of malignancy detection in 




 In the past decade, optical spectroscopic methods, such as light scattering spectroscopy, 
fluorescence spectroscopy, and Raman spectroscopy, have been comprehensively 
investigated for cancer and precancer diagnosis and evaluation [1-10, 21, 24]. Particularly, 
NIR Raman spectroscopy has received great interest for optical diagnosis of malignant 
tissues in various organs [1, 5, 7], including the larynx [10, 21, 24]. In order to convert 
molecular differences subtly reflected in Raman spectra between different tissues types 
into valuable diagnostic information for clinicians, different algorithms ranging from 
empirical approaches (e.g. intensity ratio algorithms) to sophisticated multivariate 
statistical techniques (e.g. PCA, LDA, SVM, CART, PCA-ANN) have been actively 
explored for classification of Raman spectra for precancer and cancer diagnosis [1, 11, 14, 
15, 62]. For instance, Lau et al. employed a fiber-optic rapid NIR Raman spectroscopy 
together with PCA-LDA techniques to identify laryngeal papillomatosis and squamous 
cell carcinoma with accuracies of 91 and 87%, respectively [21]. 
 
In recent years, the ensemble-based statistical techniques [121], such as random forests 
algorithm [113] have gained increased attention due to their capability of effectively 
combining multiple classifiers for data classification in biomedical areas [122-129]. For 
example, Jiang et al. introduced random forests to distinguish real microRNA precursors 
from pseudo ones with a sensitivity of 98.2% and specificity of 95.1% [122]. Wu et al. 
demonstrated that random forests algorithm could yield the highest diagnostic accuracy 
among other diagnostic algorithms such as LDA, quadratic discriminant analysis (QDA), 
k-nearest neighbor classifier, bagging and boosting classification trees and SVM, for 
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 discriminating ovarian cancer from normal serum samples using mass spectroscopy [123]. 
Despite of these successful investigations, the utility of ensemble-based algorithms on 
Raman spectroscopy for biomedical diagnosis has yet been reported in the literature. In 
this chapter, we extend our previous study on the use of CART for Raman tissue 
diagnosis, to further explore the feasibility of developing effective diagnostic algorithms 
based on an ensemble of classification trees-random forests technique for differentiation 
of NIR Raman spectra between normal and cancer tissue in the larynx [10]. 
5.1 RANDOM FORESTS THEORY 
Figure 5.1 illustrates the procedure for generating the random forests algorithm for 
classification of tissue Raman spectra. The random forests is fundamentally an ensemble 
of unpruned classification trees [113, 125]. Different trees are grown via different 
bootstrap sampling of the original dataset. In each of these growing trees, the random 
forests algorithm selects a fixed-size random subset of all variables to search for the best 
split, defined by the Gini Criterion, at every node encountered. The final diagnostic 
random forests is then constructed by combining multiple classification trees through the 








 Since random forest employed bootstrap sampling, performance of this ensemble 
classifier could be assessed with the prediction error for the objects left out in the 
bootstrap procedures. This is also known as the out-of-bag estimation (internal cross-
validation) [113]. Specifically, after each process of growing a maximal tree with a 
particular bootstrap dataset, the remaining data which were not used in the tree 
construction would constitute the “out-of-bag” dataset and be used to assess the 
respective tree prediction performance. The final predicted class of the data is calculated 
by majority vote of all the “out-of-bag” predictions on the dataset. Hence, the estimate of 
the error rate (ER) for the random forests classification algorithm is computed:  








∑                                (5.1) 
where N is the size of forest (i.e., number of trees). represents the 




based on each training dataset and Xi is on the respective out-of-bag dataset Yi. Besides 
the determination of data classification (either true positive or true negative), the voting 
outcome can also generate probability of the identification being true positive (cancer) or 
true negative (normal) for each data [124]. 
 
In this study, the number of variables to be randomly selected at each node in a tree for 
classification is approximately derived from the square root of the total number of 
available variables; the optimal size of the forests (i.e., the number of trees and the 
number of bootstrap sampling) would correspond to the smallest forest size which the 
out-of-bag error estimation stabilizes at a constant value with enlargement of forest size 
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 [125]. Based on the predicted probability for each data from the optimal forest size 
constructed from the training dataset, ROC curve was also generated by successively 
changing the thresholds to determine the probability of prediction being cancer or normal 
for all tissue Raman data.  
 
When a variable that substantially contributes to prediction performance is replaced with 
random noise, the performance of the prediction will be noticeably degraded [113, 125]. 
Conversely, if a variable is irrelevant to the prediction performance, replacing it with 
random noise only has trifle effect on the performance [125]. To assess the importance of 
different variables, the permutation accuracy importance measure is utilized in the 
random forest algorithm as shown in Figure 5.1. For each tree, the prediction accuracy on 
the out-of-bag dataset is first recorded. After which, the values of a specific variable is 
randomly permutated in all the trees, and the new predictions based on the same out-of-
bag dataset will also be recorded. Consequently, the permutation accuracy importance 
measure of a specific variable will be equivalent to the difference between the error rate 
for the new and original results based on the same out-of-bag dataset of a specific 
predictor variable, normalized by the standard error [113]. Henceforth, the larger the 
difference, the more important the predictor variable contributes towards the construction 
of the random forest [113, 125]. In this work, the variable importance algorithm defines a 
variable importance value of 1 belonging to the most important variable, whereas a 
variable importance of 0 belonging to the least important variable. 
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 5.2 EVALUATION OF RANDOM FORESTS DIAGNOSTIC ALGORITHM FOR RAMAN 
LARYNGEAL CANCER DIAGNOSIS  
5.2.1 LARYNGEAL TISSUE RAMAN DATASET  
Figure 5.2 shows the mean normalized Raman spectra of normal (n=70) and cancer 
(squamous cell carcinoma) (n=117) laryngeal tissue. Prominent Raman peaks are 
observed in both normal and cancerous laryngeal tissue, which are located at around 875 
cm-1 (C-C stretching of hydroxyproline), 935 cm-1 (C-C stretching mode of proline and 
valine in α-helix conformation), 1004 cm-1 (C-C symmetric stretch ring breathing of 
phenylalanine), 1100 cm-1 (C-C stretching of phospholipids), 1208 cm-1 (C-C6H5 
stretching mode of tryptophan and phenylalanine), 1265 cm-1 (C-N stretching and N-H 
bending modes of amide III of proteins), 1335 cm-1, (CH3CH2 twisting of proteins and 
nucleic acids), 1450 cm-1 (CH2 bending of proteins and lipids), 1552 cm-1 (C=C 
stretching mode of tryptophan), 1582 cm-1 (C=C bending mode of phenylalanine), 1601 
cm-1 (C=C in-plane bending mode of phenylalanine), 1655 cm-1 (C=O stretching of 
amide I of proteins), and 1745 cm-1 (C=O stretching of phospholipids)6,7,9-10,13-15,34, 
respectively [10]. The intensity differences between the two tissue types are remarkable. 
For example, cancer tissue show higher intensities at 935, 1265, 1335, 1450, and 1655 
cm-1, while lower at 875, 1004, 1100, 1208, 1560, 1582, 1601 and 1745 cm-1, compared 
with normal tissues. This suggests that there is an increase or decrease in the percentage 
of a certain type of biomolecules relative to the total Raman-active constituents in cancer 
tissue. There are also obvious changes of Raman peak positions and bandwidths in the 
ranges of 1100-1190 cm-1, 1200-1500 cm-1, and 1500-1800 cm-1 which are related to the 
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 C-C stretching of phospholipids, the amide III and amide I of proteins, CH3CH2 twisting 
of proteins/nucleic acids, and C=C stretching of phospholipids, respectively, for 
malignant laryngeal tissue. The differences in Raman spectra between normal and cancer 
tissue demonstrate the utility of Raman spectroscopy for laryngeal cancer diagnosis and 
detection. 










































Figure 5.2 Comparison of the mean normalized Raman spectra of normal (n=70) and 
cancer (n=117) laryngeal tissue. 
 
5.2.2 EMPLOYMENT OF RANDOM FORESTS TO THE TISSUE RAMAN DATASET  
We employ the ensemble of recursive partitioning algorithms approach (i.e., random 
forests) by incorporating the entire Raman spectra (each Raman spectrum ranging from 
800-1800 cm-1 with a set of 544 intensities) to determine the most diagnostically 
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 significant Raman features for improving tissue analysis and classification. In this study, 
the number of variables tested for each split was set to 23 (√544) and the error rate of 
different forest size from 1-1500 trees was investigated. Fig. 5.3 (a) shows the 
relationship of error rate with respect to the different number of trees. The optimal forest 
size was chosen to be at 973 when the error rate stabilizes to about 0.107 after the forest 
size is more than 972 trees. To evaluate the performance of this optimal diagnostic 
algorithm, ROC curve (Fig. 5.3 (b)) is also generated by constructing different threshold 
levels from the probability associated with each data after the majority voting. The 
integration areas under the ROC curve is 0.964 for the forest size of 973 trees, proving 
the efficacy of this random forest algorithm derived for laryngeal cancer diagnosis. The 
results show that random forests-based diagnostic algorithm is robust for laryngeal cancer 
diagnosis. 





























Figure 5.3 (a) Different error rates belonging to different sizes of the random forests (i.e., 
different number of trees) after the voting process on all the tissue Raman spectra. Due to 
the “strong law of large number”, the error rate stabilizes to 0.107 when the forest has 
more than 972 trees, highlighting that the random forests algorithm does not overfit. Note 
that each of the individual trees is grown to the maximal size and left unpruned. (b) ROC 
curve of tissue classification belonging to the final optimal random forests tree size of 973 
with an AUC of 0.964, illustrating the diagnostic ability of Raman spectroscopy and 




Figure 5.4 shows the variables importance plot based upon the construction of 973 trees 
associated with cancer transformation. The permutation accuracy importance measure 
reveals that Raman intensities at 820, 850, 870, 938, 1004, 1085, 1104, 1123, 1172, 1208, 
1240, 1314, 1335, 1370, 1421, 1490, 1552, 1576, 1601, 1672 and 1745 cm-1 are among 
the most important variables in the laryngeal tissue Raman spectra for distinguishing 
cancer from normal (at 95% confidence interval). Table 5.1 lists the tentative biochemical 
representations assigned to the significant Raman intensities. Raman intensities at these 
Raman wavenumber positions of the original dataset were subsequently subjected to 
unpaired two-sided Student’s t-test for investigating the statistical significances (p<0.05) 
between normal and cancerous tissue [10]. Raman peak intensities at 938, 1314, 1335, 
1370, 1421, and 1672 cm-1 were significantly higher for cancerous laryngeal tissue as 
compared to normal, while Raman intensities at 820, 850, 870, 1004, 1085, 1104, 1123, 
1172, 1208, 1240, 1490, 1552, and 1745 cm-1 were significantly lower for cancerous 
laryngeal tissue. Conversely, Raman intensities at 1576 and 1601 cm-1 were found not to 
be statistically significant (p=0.19 and p=0.29) for cancer diagnosis. The results indicate 
that most prominent Raman peaks, particularly in the spectral range of 820-1745 cm-1 
representing proteins, lipids and nucleic acids are the most important variables for tissue 
grouping. Hence, random forests-based permutation accuracy importance measure 
algorithm provides a novel way to identify variables which are important towards 
creating the final diagnostic model for tissue diagnosis and characterization. 
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Figure 5.4 Variables importance plot for the Raman spectral region 800-1800 cm-1 
generated from random forests size of 973 trees which was used for discrimination of 
cancer from normal laryngeal tissue. The variable importance algorithm defines the most 
important variable as 1, whereas the least important variable as 0. Major Raman spectral 
features above the bold grey line (95% confidence interval, 13.7) are identified and listed 





 Table 5.1 Tentative assignments of the Raman peaks identified in laryngeal tissue (Fig. 
5.4, variables importance plot), mean intensity changes (increase +/decrease −) of cancer 
with respect to normal, and p-values of unpaired two-sided Student’s t-test on Raman 
peak intensities of normal and cancer laryngeal tissue. 
Raman wavenumber 
(cm-1) Tentative assignment 
Mean change 
(Cancer-Normal) p-value 
820 Out-of-plane, ring breathing of tyrosine − 3E-2 
850 δ (CCH) ring breathing mode of tyrosine, Polysaccharide − 3E-3 
870 ν (C-C) of hydroxyproline − 8E-5 
938 ν (C-C) in α conformation of proline and valine + 4E-7 
1004 ν s(C-C) symmetric ring breathing of phenylalanine 
− 4E-2 
1085 ν (C-N) of proteins (lipids mode to lesser degree) 
− 2E-4 
1104 ν (C-C) of phospholipids (in gauche conformation) 
− 3E-8 
1123 ν (C-N) of proteins − 9E-11 
1172 δ (C-H) of tyrosine − 1E-6 
1208 ν (C-C6H5) of tryptophan and phenylalanine 
− 8E-8 
1240 ν (C-N), δ (N-H) amide III, α-helix of proteins 
− 7E-3 
1314 CH3CH2 twisting mode of proteins + 3E-14 
1335 CH3CH2 wagging mode of proteins and nucleic acids (DNA-purine bases) + 6E-11 
1370 Adenine, thymine, guanine + 2E-10 
1421 
δ (CH2), δ (CH3) of proteins, δ (CH2) 
scissoring of phospholipids, 
deoxyriboses 
+ 3E-2 
1490 ν (C-N) in-plane vibration of guanine  (Adenine to lesser degree) 
− 2E-8 
1552 ν (C=C) of tryptophan − 6E-3 
1576 δ (C=C) of phenylalanine − 6E-2 
1601 δ (C=C) (in-plane) of phenylalanine − 3E-1 
1672 
ν (C=O) of amide I in β-helix 
conformation of proteins, C=C lipid 
stretch 
+ 4E-7 
1745 ν (C=O) of phospholipids − 9E-8 
 




 Figure 5.5 displays the probabilistic classification results based on the random forests 
technique together with the leave-one sample (i.e., all spectra associated with the 
sample)-out, cross validation method. The random forests diagnostic algorithm yields the 
diagnostic sensitivity of 88.0%, and specificity of 91.4% for separating cancer from 
normal laryngeal tissues. The results show that Raman spectroscopic technique combined 
with the random forests diagnostic algorithm is robust and powerful for cancer diagnosis. 




















Figure 5.5 Scatter plot of the generated probabilistic scores belonging to the normal and 
cancer categories using the random forests technique together with leave-one sample-out, 
cross validation method. The separate line yields a diagnostic sensitivity of 88.0% 
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 (103/117) and specificity of 91.4% (64/70) for differentiation between normal and cancer 
laryngeal tissue.  
 
Raman spectroscopy holds great promise for molecular diagnosis of different tissue types 
in biomedicine [1,5, 7, 10]. To harvest the great wealth of biomolecular information of 
complex tissue contained in Raman spectra for reliable diagnostic applications, different 
multivariate statistical algorithms have been extensively investigated [1, 6, 11, 14, 15, 62]. 
In this study, we developed a robust random forests algorithm using the ensemble of 
classification trees for Raman spectroscopic diagnosis of laryngeal cancer. The result 
shows that the developed random forests algorithm based on the tissue Raman dataset 
yields a predictive diagnostic sensitivity of 88.0% (103/117), specificity of 91.4% (64/70), 
and overall accuracy of 89.3% (167/187) for laryngeal cancer detection. Since the 
original motivation for the development of random forests algorithm was to enhance the 
classification accuracy of single classification tree (i.e., CART technique), for 
comparison purposes, we also apply the CART technique combined with the leave-one 
sample-out, cross-validation method on the same tissue Raman dataset. We found that a 
predictive sensitivity of 82.9% (97/117), specificity of 81.4% (57/70) and accuracy of 
82.4% (154/187) can be obtained for using CART algorithm on laryngeal cancer 
diagnosis. Clearly, the random forests diagnostic algorithm can give a fairly higher level 
of diagnostic accuracy compared to the CART model, indicating that an ensemble-based 
algorithm is more powerful than a single classifier technique. This is probably due to the 
fact that effective ensemble-based algorithms generally possess the properties of low 
biasness, low variance, and low correlations of classifiers (diversity) for data 
classification [130, 131]. Also, the combination of unpruned trees inherently preserves 
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 low biasness and variance, and the limited number of predictors generated at each node in 
a tree also ensures that correlations among the resultant classification trees are very small 
[125], leading to the improved classification performance of the ensemble-based 
technique (random forests) for cancer identification as compared to the CART algorithm. 
Furthermore, through the employment of the majority voting procedure for the ensemble 
of multiple tree classifiers, the random forests diagnostic model could also generate 
probability of acquired spectra belonging to cancer or normal group (Fig. 5.5). This 
facilitates the clinicians to effectively assess the accuracy of the predicted tissue types or 
pathologies associated with NIR Raman spectroscopy technique. On top of these, the 
random forests algorithm possesses an inherent characteristic that the error rate can 
converge to an asymptotic value due to the “strong law of large number” thereby 
enabling this diagnostic algorithm to be resistant towards overfitting for tissue 
classification (Figure 5.3(a)) [132]. These further confirm that the ensemble-based 
random forests diagnostic technique together with NIR Raman spectroscopy is robust and 
powerful for laryngeal tissue diagnosis and characterization. 
 
Currently, most of the diagnostic algorithms (e.g. PCA-LDA, SVM, logistic regression,) 
employed in Raman spectroscopy diagnosis of diseased tissue could not adequately 
furnish the clinicians with physical meanings of diagnostic features derived for tissue 
characterization [1, 6, 11, 14, 15, 62]. Hence, the development of robust algorithms 
which not only produce a high predicted diagnostic accuracy, but also provide useful 
biomolecular diagnostic information from the high dimensional Raman spectral datasets 
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 is highly desirable. As the random forests algorithm provides the permutation accuracy 
importance measure [133] to uncover the disease-related biochemical changes of Raman 
spectra that can correlate with tissue pathologies, we have constructed the robust random 
forests diagnostic model for distinguishing laryngeal cancer [10]. We found that the 
ensemble-based classification trees diagnostic algorithm could be used to select 
distinctive spectral regions that are optimal for tissue differentiation. We have identified 
twenty-one significant Raman features related to particular biochemical and biomolecular 
changes (e.g. proteins, lipids, nucleic acids, and carbohydrates) that are associated with 
cancer transformation in the larynx (Fig. 5.4 and Table 5.1). For instance, the Raman 
intensity at 1672 cm-1 has been found to be one of the most important Raman features in 
the construction of random forests-based diagnostic model for discriminating malignancy 
from normal laryngeal tissue (Fig. 5). The finding is consistent with Huang et al.’s report 
on the observation of a shoulder band at 1668 cm-1 in malignant lung tissue [5]. This 
suggests that laryngeal cancerous transformation could be related with an increase in the 
relative amounts of proteins in the β-pleated sheet or random coil conformation, and 
lipids [5, 10].  In addition, the Raman intensities at 820, 850 and 1172 cm-1 that are 
presumably ascribed to tyrosine [10] are also found to be significantly lower for cancer, 
indicating the decrease of tyrosine with laryngeal malignancy. These findings are in 
agreement with Verschuur et al.’s study [134] in which the activities of protein tyrosine 
kinases were found to be lower for head and neck squamous cell carcinoma. On top of 
this, Raman intensities at 938, 1004, 1208, 1552, 1576 and 1601 cm-1 that are 
representative of different amino acids such as proline, valine, phenylalanine and 
tryptophan, and Raman intensities at 1085, 1123, 1240, 1314 cm-1 for proteins in general 
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 are also found to play pivotal roles towards tissue classification. This may signify 
significant changes of different proteomic activities (e.g. enzymatic, hormones and etc) 
with malignancy which could be an indication of increase of mitotic activities in 
cancerous cells [10]. Furthermore, Raman intensity at 875 cm-1 has been found to 
decrease significantly with malignancy, signifying a reduce in the percentage of collagen 
contents relative to the total Raman-active components in the stroma layer of cancer 
tissue. This observation coincides with the report in literature that cancerous cells 
proliferate, invade into underlying layer, and express as a class of metalloproteases 
leading to a decrease in the amount of collagen level [93]. Besides, the thickening of the 
epithelium associated with cancerous progression may attenuate the excitation laser 
power and also obscure the collagen Raman emission from the deep collagen basal 
membrane, thereby resulting in an overall decrease of Raman intensity at 875 cm-1 [135]. 
We also observed that the Raman intensities at 1335, 1370, 1421, 1490 cm-1 that mainly 
represent nucleic acids are generally higher for cancer laryngeal tissue, whereas Raman 
intensities at 1104 and 1745 cm-1 for phospholipids are lower as compared to normal 
tissue. These results are in consistent with the findings of the increase of nucleic acids to 
lipids ratio in cancerous tissues in literature [10, 136]. Since the random forests has taken 
into account of the massive multiple interactions among different Raman intensities (544 
variables), the random forests algorithm is able to capture diagnostically significant 
features contained in the Raman spectra. Hence, the random forests algorithm is robust 
and powerful for distinguishing the origins of biochemical/biomolecular changes of 




 To conclude for this chapter, significant differences in Raman spectra are found between 
normal and cancer tissue in this study, demonstrating the utility of Raman spectroscopy 
for laryngeal cancer detection. We have also employed the random forests technique for 
the first time to develop the random recursive partitioning ensemble algorithms to realize 
effective classification of Raman spectra between normal and cancer laryngeal tissue [10]. 
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 CHAPTER 6  
EMPIRICAL STATISTICAL ANALYSIS FOR GASTRIC PRECANCER 
DIAGNOSIS 
Gastric cancer is among one of the most common malignancies worldwide and it 
continues to be one of the worst 5-year survival rate statistics among other malignancies 
[137, 138]. Increasing the survival rate of patients with gastric cancer is important and 
recent statistics have shown that if diagnosis occurs at an early stage for gastric cancer, 
the 5-year survival rate of the patient is expected to be higher than 90% [102, 103]. Hence, 
early diagnosis of gastric cancer represents the most important measure to decreasing 
disease-associated mortality [139]. Additionally, the identification of gastric precancer 
(i.e., dysplasia) would offer the best prognosis as it is essential for planning optimal 
therapy, particularly for photodynamic therapy, endoscopic submucosal dissection (ESD) 
or endoscopic mucosal resection (EMR), as compare to surgery and chemotherapy [140]. 
However, early detection of gastric dysplasia renders a great challenge to the 
endoscopists as these flat lesions are usually lack of obvious gross morphological 
changes to be visualized under conventional white-light endoscopy. 
 
NIR Raman spectroscopy has received much interest for optical diagnosis of diseased 
tissue in a number of organs [1-5-10], including malignant tumor in the stomach [12, 14, 
16, 25-28]. To correlate the Raman spectral changes with different pathologic conditions 
in a straight forward way, the nonparametric diagnostic algorithms based on prominent 
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 tissue Raman bands intensities and/or intensity ratios have been practiced for effective 
distinction of gastric cancer from normal mucosa tissue. Diagnostic algorithms derived 
from intensity ratios is advantageous as it could provide tissue diagnosis with being 
inherently independent of Raman spectroscopic measurement conditions such as 
excitation/detection geometries, excitation light power fluctuations, probe-tissue 
positioning variations, etc [141]. With the potential of Raman intensity ratio diagnostic 
algorithms to also amplify the molecular distinction between normal and cancer tissues 
for better tissue classification, Hu et al. utilized the Raman peak intensities ratios of 
I1587/I1156 and I1156/I1660 to successfully discriminate malignant tissue from normal 
stomach tissue with a diagnostic accuracy of nearly 100% [28]. Very recently, Kawabata 
et al. reported that simply using a Raman band intensity at 1644 cm-1 for proteins of NIR 
Raman spectra could yield a diagnostic accuracy of 70% for 123 neoplastic and 128 non-
neoplastic gastric tissue samples, which was close to the diagnostic accuracy level 
produced by the multivariate statistical techniques (e.g., PCA, LDA) [27]. These work 
highlighted the high efficacy of Raman spectroscopy associated with prominent Raman 
peak intensities or intensity ratios for gastric cancer detection. In this chapter, we explore 
the potential of NIR Raman spectroscopy (at 785 nm excitation) in conjunction with 
pairwise combinations of different Raman peak intensity ratios as diagnostic algorithms 
for identifying dysplasia from normal gastric mucosa tissue [16]. 
6.1 COMPARISON OF SPECTRAL DIFFERENCES BETWEEN NORMAL AND 
DYSPLASIA GASTRIC TISSUES 
Figure 6.1(a) shows the mean normalized NIR Raman spectra of normal (n=44) and 
dysplasia (n=21) gastric tissues. A comparison of Raman spectra of dysplasia tissue with 
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 respect to the normal reveals remarkable differences in spectral shapes and intensities 
(Figure 6.1(b)), with dysplasia tissue showing lower intensities at 875, 1004, 1100, 1208 
and 1745 cm-1, while being higher at 1265, 1335, 1450 and 1655 cm-1, respectively. 
There are also obvious changes of Raman peak positions and bandwidths in the spectral 
ranges of 1200-1500 cm-1, and 1600-1700 cm-1 which are related to the amide III and 
amide I of proteins, CH3CH2 twisting of proteins/nucleic acids, and CH2 bending mode of 
proteins and lipids for dysplasia. Hence, the significant differences in Raman spectra 
between normal and dysplasia tissue confirm a potential role of NIR Raman spectroscopy 
for precancer diagnosis in the stomach. 
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Figure 6.1 (a) The mean normalized NIR Raman spectra from normal (n=44) and 
dysplasia (n=21) gastric mucosa tissue samples; (b) Difference spectrum ± 1.96 SD 
calculated from the mean Raman spectra between normal and dysplasia tissue (i.e., the 
mean normalized Raman spectrum of dysplasia tissue minus the mean normalized Raman 
spectrum of normal tissue). Solid and dotted lines represent the mean spectra, and shaded 
areas indicate the variance within 95% confidence interval of the mean difference of the 
respective spectra. 
 
This result shows that there are distinctive spectral differences between dysplasia and 
normal gastric tissue [16]. For example, Raman peak intensity at 875 cm-1 
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 (hydroxyproline of collagen) was found to be much reduced in dysplastic tissue. This was 
probably due to the cytoplasmic mucin depletion and the elevated concentration of 
metalloproteinase which cleaved collagen in the stroma layer in gastric dysplasia. In 
addition, the thickening of the epithelium associated with dysplastic progression may 
attenuate the excitation laser power and also obscure the collagen Raman emission from 
the deep collagen basal membrane, thereby resulting in an overall decrease of Raman 
intensity at 875 cm-1 from dysplasia tissue [16]. Raman bands for essential amino acids at 
1004 and 1208 cm-1 (phenylalanine and tryptophan) show lower percentage signals for 
dysplasia compared to the normal, indicating a decrease in the percentage of 
phenylalanine and tryptophan relative to the total Raman-active constituents in the 
dysplasia. This is consistent with Alimova et al.’s report on a decrease in the tryptophan 
phosphorescence signal associated with malignancies in breast tissues [142], and also in 
agreement with Worthington et al.’s study that established a link between essential amino 
acids deficiency (e.g., phenylalanine) and carcinogenesis [143]. Similarly, in accord with 
Huang et al. Raman studies on lung cancer diagnosis [5], Raman peaks at around 1100 
and 1745 cm-1 also show lower intensities for gastric dysplasia, indicating the decrease of 
Raman signals related to different vibrational modes from the hydrophobic chains of 
phospholipids which make up the membranes of the cell and numerous organelles inside 
the cytoplasm of the cell. On the other hand, the Raman bands at 1265 and 1655 cm-1 for 
histones (α-helical proteins surrounding the DNA) are significantly higher in dysplasia 
than normal, suggesting that hyperchromatism may take place in the nucleus with 
neoplastic transformation in the gastric [144]. Furthermore, the intensity of Raman peak 
at 1450 cm-1 (CH2 proteins/lipids) and the bandwidths of Raman peaks at 1335 cm-1 
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 (CH3CH2 twisting of proteins and nucleic acids) and at 1655 cm-1 (amide I band of 
proteins) have also been found to change (e.g., intensity increase; bandwidth widening 
and peak shift, as shown in Figure 6.1) with dysplastic transformation, and these 
biomolecular changes could be related to the increase of mitotic activity occurring in the 
nucleus [145]. As a result, the distinctive differences in Raman spectra between normal 
and dysplasia gastric tissue reinforce that Raman spectroscopy can be used to reveal 
cellular and molecular changes associated with dysplastic transformation. 
6.2 RAMAN INTENSITY RATIO  
The nonparametric analysis based on intensity ratios of prominent Raman bands which 
were identified from the difference spectrum in Figure 6.1(b) is explored for tissue 
diagnosis in a straightforward way. Figure 6.2 shows box charts of the 6 significant 
Raman peak intensity ratios of I875/I1450, I1004/I1450, I1100/I1450, I1208/I1450, I1745/I1450 and 
I1208/I1655 (unpaired two-sided Student’s t-test, p <0.0001) correlated with their 
histopathologic findings. Each ratio belonging to normal tissue is significantly higher 
than that of dysplasia tissue, and the corresponding separation lines (i.e., diagnostic 
algorithms), as shown in Figure 6.2(a-f), classify dysplasia from normal with a sensitivity 
of 76.2%, 81.0%, 95.2%, 81.0%, 95.2%, and 76.2%, and a specificity of 90.9%, 90.9%, 
77.3%, 88.6%, 75.0%, and 84.1%, respectively. These results indicate that different ratios 

























































































































Figure 6.2 Box charts of the 6 significant Raman peak intensity ratios which can 
differentiate dysplasia from normal gastric mucosa tissue (unpaired Student’s t-test, 
p<0.0001): (a) I875/I1450; (b) I1004/I1450; (c) I1100/I1450; (d) I1208/I1450; (e) I1745/I1450, and (f) 
I1208/I1655. The dotted lines (I875/I1450 = 0.67; I1004/I1450 =0.77; I1100/I1450 = 0.71; I1208/I1450 = 
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 0.37; I1745/I1450 = 0.26; I1208/I1655 = 0.61) as diagnostic threshold algorithms classify 
dysplasia from normal with sensitivity of 76.2% (16/21), 81.0% (17/21), 95.2% (20/21), 
81.0% (17/21), 95.2% (20/21), and 76.2% (16/21); specificity of 90.9% (40/44), 90.9% 
(40/44), 77.3% (34/44), 88.6% (39/44), 75.0% (33/44), and 84.1% (37/44), respectively.  
 
Given the potential of Raman intensity ratios approach to amplifying the molecular 
distinction between different pathological groups as well as the ability of achieving the 
biomolecular diagnosis independent of Raman measurement conditions such as excitation 
light power fluctuation or probe positioning variation [141], we have comprehensively 
investigated different prominent Raman intensity ratios as nonparametric diagnostic 
algorithms for classifying dysplasia from normal gastric tissue. As a result, 6 
diagnostically significant ratios were found to be able to enhance the molecular 
differences between normal and dysplasia tissues. For instance, the intensity ratio of 
Raman peak intensity at 875 cm-1 (hydroxyproline of collagen) to the peak at 1450 cm-1 
(CH2 mode of proteins and lipids) yielded a diagnostic sensitivity of 76.2% and 
specificity of 90.9% for separating dysplasia from normal tissue. Further investigation 
also shows that other intensity ratios such as the Raman peak intensity bands for essential 
amino acids at 1004 cm-1 and at 1208 cm-1 to the Raman peak intensity at 1450 cm-1 also 
provide good differentiation between normal and dysplasia tissue. The significant 
differences of these intensity ratios between normal and dysplasia tissue may reflect the 
relative changes in the concentration of potential biological markers ranging from cell 
surface antigens, cytoplasmic proteins and mucin, collagen in the extracellular matrix, 
enzymes, and hormones associated with dysplastic changes [16]. Hence, the Raman 
intensity ratios could be utilized for dysplasia identification in the gastric. 
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 6.3 OPTIMAL RAMAN INTENSITY RATIO DIAGNOSTIC ALGORITHM  
To further improve the discriminative ability of the empirical approach but yet allowing 
interpretations of diagnostic results in a straightforward manner, we also extensively 
explored the possible pairwise combinations of different Raman intensity ratios for tissue 
diagnosis and classification (Table 6.1). Table 6.1 shows the results of predicted 
diagnostic sensitivity, specificity and accuracy using 15 pairwise combinations of the 
significant Raman peak intensity ratios for tissue classification. The combination of 
I1208/I1655 and I875/I1450 is one of the optimal diagnostic algorithms for discriminating 
dysplasia from normal gastric tissue. Figure 6.3(a) presents the scatter plot of combining 
the intensity ratios of I1208/I1655 and I875/I1450 for different pathologic types. The linear 
discrimination line (I1208/I1655 = -0.81 I875/I1450 + 1.17) generated from the logistic 
regression analysis together with the leave-one sample-out, cross-validation method gives 
a diagnostic sensitivity of 90.5% and specificity of 90.9% for separating dysplastic tissue 
from normal gastric tissues. To further evaluate the performance of this optimal 
diagnostic algorithm, receiver operating characteristic (ROC) curve (Figure 6.3(b)) is also 
produced from the scatter plot in Figures 6.3(a) at different threshold levels. The 
integration areas under the ROC curve is 0.96 for the combined Raman peak intensity 
ratios, proving the robustness of this nonparametric algorithm derived for gastric 




 Table 6.1 Results of predicted sensitivity, specificity and accuracy for discrimination of 
gastric dysplasia from gastric normal tissue using the pairwise combinations of Raman 
peak intensity ratios. 
After leave-one sample-out cross validation (Predicted) 
Diagnostic Pairwise Combinations 
Sensitivity Specificity Accuracy 
I1004/1450 80.9% (17/21) 90.9% (40/44) 87.7%(57/65) 
I1100/1450 85.7% (18/21) 88.6% (39/44) 87.7%(57/65) 
I1208/1450 76.1% (16/21) 88.6% (39/44) 84.6% (55/65) 
I1745/1450 85.7% (18/21) 84.1% (37/44) 84.6% (55/65) 
I875/1450 v.s. 
*I1208/1655 90.5% (19/21) 90.9% (40/44) 90.8% (59/65) 
I1100/1450 76.1% (16/21) 90.9% (40/44) 86.2% (56/65) 
I1208/1450 76.1% (16/21) 86.4% (38/44) 83.1% (54/65) 
I1745/1450 76.1% (16/21) 86.4% (38/44) 83.1% (54/65) 
I1004/1450 v.s. 
I1208/1655 80.9% (17/21) 88.6% (39/44) 86.2% (56/65) 
I1208/1450 80.9% (17/21) 88.6% (39/44) 86.2% (56/65) 
I1745/1450 76.1% (16/21) 84.1% (37/44) 81.5% (53/65) I1100/1450 v.s. 
I1208/1655 80.9% (17/21) 90.9% (40/44) 87.7%(57/65) 
I1745/1450 76.1% (16/21) 86.4% (38/44) 83.1% (54/65) 
I1208/1450 v.s. 
I1208/1655 80.9% (17/21) 90.9% (40/44) 87.7%(57/65) 
I1745/1450 v.s. I1208/1655 76.1% (16/21) 84.1% (37/44) 81.5% (53/65) 
Note:  
The symbol * denotes the pairwise combination of Raman peak intensity ratios with the 
highest sensitivity, specificity and accuracy values (lowest estimated generalization error) 








































Figure 6.3 (a) Two-dimensional scatter plot showing the distribution of normal and 
dysplastic gastric mucosa tissues after combining both Raman peak intensity ratios of 
I1208/I1655 and I875/I1450 as a discriminating algorithm. A linear diagnostic decision 
algorithm (I1208/I1655 = -0.81 I875/I1450 + 1.17) yields a sensitivity of 90.5% (19/21) and a 
specificity of 90.9% (40/44) for separating dysplasia from normal tissue. (b) Receiver 
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 operating characteristic (ROC) curve with an area under curve (AUC) of 0.96 illustrates 
the ability of Raman spectroscopy to identify dysplasia from normal gastric tissues. 
 
The logistic regression analysis coupled with leave-one sample-out, cross validation, as 
well as ROC analysis for unbiased evaluation on different 2-dimensional diagnostic 
models indicate that the combined intensity ratios of I1208/I1655 and I875/I1450 can serve as 
one of the most effective ratio diagnostic algorithms for dysplasia identification. Even 
though the simplistic empirical analysis here could only utilize up to four prominent 
Raman peaks each time for tissue classification, these algorithms still contained a mixture 
of different biomolecular diagnostic information ranging from the nucleus and cytoplasm 
within the cell, to the extracellular matrix outside the cell. For example, the 
nonparametric algorithm (I1208/I1655 and I875/I1450) contained the diagnostic information 
that are specifically extracted from collagen present in the extracellular matrix, essential 
amino acids and CH2 of proteins/lipids found mostly in tissues and cells, and also 
histones which are present in the nucleus [5, 6]. Hence, the Raman intensity ratios 
derived in this work could potentially be used as effective diagnostic algorithms for 
classifying dysplasia from normal gastric tissue. One notes that the intensity ratio 
analysis employs the selection of a group of diagnostic Raman intensity features directly 
derived from the tissue Raman spectra to construct the classification model for tissue 
diagnosis. Other powerful multivariate feature selection algorithms (e.g. random forests) 
that take into consideration of the interactions among different spectral features could 
also be applied to choose the best subset of Raman features for effective tissue 
classification. Alternatively, multivariate statistical techniques such as PCA-LDA, which 
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 fully utilize diagnostically significant features contained in the entire Raman spectrum 
and transform them into multiple independent linear combinations of the original spectral 
features, could be used for further improving diagnostic efficacy for gastric precancer 
diagnosis and classification. Note that a detailed comparison of the PCA-LDA with the 
Raman intensity ratio algorithm will be discussed in the following chapter [12].  
 
In conclusion, this study shows that there are significant differences in Raman spectra 
between normal and dysplastic gastric tissue, demonstrating the utility of NIR Raman 
spectroscopy for differentiating dysplasia from normal tissue in the stomach. 
Furthermore, with the use of Raman intensity ratios as diagnostic algorithms, NIR Raman 
spectroscopy could be a clinically useful tool for rapid, noninvasive, in vivo diagnosis 
and detection of gastric precancer at the molecular level [16].  
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 CHAPTER 7  
COMPARISON OF PERFORMANCE FOR MULTIVARIATE 
STATISTICAL ANALYSIS AND EMPIRICAL STATISTICAL ANALYSIS 
FOR GASTRIC DYSPLASIA DIAGNOSIS 
The current gold standard for clinical diagnosis of gastric dysplasia is through 
histological observation by the pathologist, on the extent of cytological and architectural 
abnormalities of the histologically prepared tissue samples [145]. These abnormalities 
involve much molecular alterations which could also be tapped upon for diagnosis, most 
importantly during routine endoscopic inspection [145]. Hence, Raman spectroscopy that 
is capable of providing rich biochemical and biomolecular information about tissue may 
be the promising diagnostic tool to be used for molecular discrimination of gastric 
dysplasia. However, as gastric dysplasia belongs to part of a widely accepted multi-step, 
continuum progression cascade from normal gastric tissue to adenocarcinoma [146], it 
implies gastric dysplasia’s vague molecular distinction that may render characterization 
and discrimination tougher for Raman spectral analysis. As shown in previous chapter 
(i.e., Figure 6.1), the Raman spectral pattern between normal and dysplastic gastric 
tissues could be very similar, it is highly desirable to develop robust diagnostic 
approaches to extract all possible diagnostic information contained in tissue Raman 
spectra for well correlation with tissue changes associated with neoplastic transformation. 
Consequently, with a larger sample size, both empirical and statistical techniques were 
examined in detail in this chapter for a more robust evaluation to attain the likelihood of 
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 good clinical discriminators of Raman spectra for separation between normal and 
dysplastic gastric tissues [12].  
7.1 ANALYTICAL APPROACHES 
7.1.1 EMPIRICAL APPROACH: INTENSITY RATIO 
Nonparametric diagnostic algorithms based on peak intensities, spectral bandwidths, 
and/or peak ratios have been widely employed in literature to correlate the variations of 
tissue spectra with tissue pathology in a simple and straightforward fashion [5, 20]. In 
this chapter, the empirical diagnostic algorithm based on the ratio of the Raman peak 
intensity at 875 cm-1 for hydroxyproline to the peak intensity at 1450 cm-1 for CH2 
proteins/lipids was selected for tissue classification. Figure 7.1 shows an example of the 
scatter plot of the ratio of Raman intensity at 875 cm-1 to that at 1450 cm-1 grouped 
according to tissue pathologic types. The mean value (mean± SD) of this ratio for normal 
tissues (1.13 ± 0.46, n=55) is significantly different from the mean value for dysplastic 
tissues (0.52 ± 0.33, n=21) (unpaired two-sided Student’s t-test, p <0.00001). The 
decision line (I875/I1450 = 0.717) discriminates dysplasia tissue from normal gastric tissue 






















Figure 7.1 Scatter plot of the intensity ratio of Raman signals at 875 cm-1 and 1450 cm-1, 
as measured for each sample and classified according to the histological results. The 
mean intensity (1.13 ± 0.46,) of normal tissue is significantly different from the mean 
value (0.52 ± 0.33) of dysplasia tissue (unpaired Student’s t-test, p<0.00001). The 
decision line (I875/I1450 = 0.717) separates dysplasia tissue from normal tissue with a 
sensitivity of 85.7% (18/21) and specificity of 80.0% (44/55).  
 
7.1.2 MULTIVARIATE ANALYSIS: PCA 
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The high dimension of Raman spectral space (each Raman spectrum ranging from 800-
1800 cm-1 with a set of 544 intensities) will result in computational complexity and 
inefficiency in optimization and implementation of the LDA algorithms. As such, PCA 
was firstly performed on tissue Raman dataset to reduce the dimension of Raman spectral 
space while retaining the most diagnostically significant information for tissue 
classification. To eliminate the influence of inter and/or intra-subject spectral variability 
 
 on PCA, the entire spectra were standardized so that the mean of the spectra was zero and 
the standard deviation of all the spectral intensities was one. Mean centering ensures that 
the principal components (PCs) form an orthogonal basis [12]. The standardized Raman 
data sets were assembled into data matrices with wavenumber columns and individual 
case rows. Thus, PCA was performed on the standardized spectral data matrices to 
generate PCs comprising a reduced number of orthogonal variables that accounted for 
most of the total variance in original spectra. Each loading vector is related to the original 
spectrum by a variable called the PC score, which represents the weight of that particular 
component against the basis spectrum. PC scores reflect the differences between different 
classes. Unpaired Student’s t-test was used to identify the most diagnostically significant 
PCs (p<0.05) and showed that there were four PCs (PC1, PC2, PC4, and PC5) that were 
diagnostically significant (p<0.05) for discriminating dysplasia tissue from normal tissue 
[12]. Figure 7.2 displays the four significant PCs scores calculated from PCA on the 
Raman spectra. The first PC accounts for the largest variance (e.g. 42.6% of the total 
variance), whereas the successive PCs describe the spectral features that contribute 
progressively smaller variances. Some PC features (Figure 7.2 (a) – (d)), such as peaks, 
troughs, spectral shapes, are similar to those of tissue Raman spectra.  
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Figure 7.2 The first four diagnostically significant principal components (PCs) 
accounting for about 78.5% of the total variance calculated from Raman spectra (PC1 – 
42.6%, PC2 – 25.4%, PC4 – 7.9%, and PC5 – 2.6%), revealing the diagnostically 
significant spectral features for tissue classification. 
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Figure 7.3 shows the correlations between the diagnostically significant PC scores for 
normal and dysplastic gastric tissue, illustrating the utility of PC scores for classification 
of Raman spectra between different tissue types. Normal and dysplasia tissues can be 
largely clustered into two separate groups based on different combinations of significant 
PCs, and the corresponding separation lines (i.e., diagnostic algorithms) in Figure 7.3 (a-f) 
classify dysplasia from normal tissue with the sensitivity of 90.5% (19/21), 76.2% 
(16/21), 71.4% (15/21), 81.0% (17/21), 71.4% (15/21), and 71.4% (15/21); specificity of 
 
 90.9% (50/55), 80.0% (44/55), 83.6% (46/55), 80.0% (44/55), 72.7% (40/55), and 72.7% 
(40/55), respectively. These results show that selection of different combinations of 
significant PCs will give different levels of accuracy for tissue classification.   




































































Figure 7.3 Scatter plots of the diagnostically significantly PC scores for normal and 
dysplastic gastric tissue derived from Raman spectra, (a) PC1 vs. PC2; (b) PC1 vs. PC4; 
(c) PC1 vs. PC5; (d) PC2 vs. PC4; (e) PC2 vs. PC5; (f) PC4 vs. PC5. The dotted lines 
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 (PC2= 1.46 PC1 + 1.34; PC4= -1.32 PC1 + 0.94; PC5= -2.16 PC1 – 0.89; PC4= 1.74 
PC2 + 0.12; PC5= 0.  84 PC2 – 0.381; PC5= -2.05 PC4 – 0.29) as diagnostic algorithms 
classify dysplasia from normal with sensitivity of 90.5% (19/21), 76.2% (16/21), 71.4% 
(15/21), 81.0% (17/21), 71.4% (15/21), and 71.4% (15/21); specificity of 90.9% (50/55), 
80.0% (44/55), 83.6% (46/55), 80.0% (44/55), 72.7% (40/55), and 72.7% (40/55), 
respectively. Circle (○): normal; Triangle (▲): dysplasia.   
 
7.1.2 MULTIVARIATE ANALYSIS: LDA 
To further improve tissue diagnosis, all the four diagnostically significant PCs were 
loaded into the LDA model for generating effective diagnostic algorithms for tissue 
classification. LDA determines the discriminant function that maximizes the variances in 
the data between groups while minimizing the variances between members of the same 
group [12]. The performance of the diagnostic algorithms rendered by the LDA models 
for correctly predicting the tissue groups (i.e., normal vs. dysplasia) was estimated in an 
unbiased manner using the leave-one sample-out, cross validation method on all model 
spectra. In this method, one sample (i.e., one spectrum) was held out from the data set 
and the entire algorithm including PCA and LDA was redeveloped using the remaining 
tissue spectra. The algorithm was then used to classify the withheld spectrum. This 
process was repeated until all withheld spectra were classified.  
 
Figure 7.4 shows the classification results based on PCA-LDA technique together with 
leave-one spectrum-out, cross-validation method. The PCA-LDA  diagnostic algorithms 
yielded the diagnostic sensitivity of 95.2% and specificity 90.9% for separating dysplasia 
from normal gastric tissues. 
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Figure 7.4 Scatter plot of the linear discriminant scores of belonging to the normal and 
dysplasia categories using the PCA-LDA technique together with leave-one spectrum-out, 
cross-validation method. The separate line yields a diagnostic sensitivity of 95.2% (20/21) 
and specificity of 90.9% (50/55) for differentiation between normal and dysplasia tissue. 
 
7.1.3 COMPARISON OF PERFORMANCE FOR DIFFERENT ANALYTIC TECHNIQUES: 
ROC 
To evaluate and compare the performance of the PCA-LDA-based diagnostic algorithms 
derived from all the significant PCs of tissue Raman dataset against the empirical 
approach-based diagnostic algorithm derived from the intensity ratio of I875/I1450, the 
ROC curves (Figure 7.5) were generated from the scatter plots in Figures 7.2 and 7.4 at 
different threshold levels, displaying the discrimination results using both diagnostic 
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 algorithms. A comparative evaluation of the ROC curves indicates that PCA-LDA-based 
diagnostic algorithm gives more effective diagnostic capability for detection of gastric 
dysplasia from normal gastric tissues, as illustrated by the improvement in the diagnostic 
sensitivity and specificity. The integration areas under the ROC curves are 0.98 and 0.88 
for PCA-LDA-based diagnostic algorithms and the nonparametric intensity ratio 
algorithm, respectively. These results demonstrate that PCA-LDA-based diagnostic 
algorithms that utilized the entire spectral features of Raman spectra yield a better 
diagnostics accuracy than the empirical approach.  














 I875 / I1450 
 
Figure 7.5 Comparison of ROC curves of discrimination results for Raman spectra 
utilizing the PCA-LDA-based spectral classification with leave-one spectrum-out, cross-
validation method and the empirical approach using Raman intensity ratio of I875/I1450. 
The integration areas under the ROC curves are 0.98 and 0.88 for PCA-LDA-based 
diagnostic algorithm and intensity ratio algorithm, respectively, demonstrating the 




The simplistic empirical analysis above only employs a limited number of Raman peaks 
for tissue diagnosis, most of the information contained in the Raman spectra has not been 
used for spectral analysis [12]. Since biological tissue is complex, it is likely that there 
are many biochemical species influencing diseases concurrently. Therefore, a 
multivariate statistical analysis (e.g., PCA and LDA) that utilizes the entire spectrum to 
determine the most diagnostically significant spectral features may improve the 
diagnostic efficiency of Raman technique for tissue analysis and classification. As such, 
PCA-LDA together with cross-validation technique was applied in this work to the NIR 
Raman spectra acquired for dysplasia tissue identification. The unpaired, two-sided 
Student’s t-test identified that only a few PCs (PC1, PC2, PC4 and PC5) contained the 
most diagnostically significant information (p<0.05) for tissue classification. We note 
that one of the most statistically significant PCs (e.g., PC5) only describes small amount 
(2.6%) of the total variance. This indicates that some PCs with small variances can still 
contain the useful diagnostic information for revealing molecular changes with dysplastic 
transformation. However, since the noise present in weak tissue Raman signals may 
affect the determination of significant PCs with smaller variances for tissue diagnosis, 
caution should be taken when acquiring the weak tissue Raman signals [147]. Hence, the 
rapid fiber-optic Raman system with a high signal-to-noise ratio (3.3-16 folds 
improvement) [46] was employed to obtain high quality Raman tissue spectra, and an 
appropriate data preprocessing was also introduced for further reducing the noise 
interference in PC analysis. The consistency in identifying similar significant PC scores 
from run to run during the leave-one spectrum-out, cross-validation testing suggested that 
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 the diagnostic algorithms developed were robust for Raman spectral analysis in this study. 
To develop effective diagnostic algorithms for tissue classification, all the four 
diagnostically significant PCs were utilized in the LDA model. The diagnostic sensitivity 
and specificity of 95.2% and 90.9% for identifying dysplasia from normal gastric tissue 
can be achieved using the PCA-LDA model, which had almost a 10% improvement in 
diagnostic accuracy compared to the empirical method. ROC analysis (Figure 7.5) further 
confirms that PCA-LDA-based diagnostic algorithms employing the entire spectral 
features of Raman spectra are more robust and powerful in distinguishing dysplasia from 
normal tissue. 
 
In conclusion, this work proved that multivariate statistical technique provided a higher 
accuracy performance compared to the intensity ratio method for NIR Raman 
spectroscopy detection of gastric precancer [12]. Therefore, NIR Raman spectroscopy in 
conjunction with multivariate statistical technique has potential for rapid diagnosis of 




 CHAPTER 8  
RANDOM FORESTS DEMONSTRATION FOR GASTRIC PRECANCER 
DETECTION 
PCA is primarily for data reduction rather than for identification of biochemical or 
biomolecular components of tissue [12]. It is usually difficult to interpret the physical 
meanings of the component spectra [12]. However, with more powerful diagnostic 
algorithms (e.g., random forests) [10], distinctive spectral regions that are optimal for 
tissue differentiation may be identified and related to particular biochemical and 
biomolecular changes (e.g., proteins, lipids, nucleic acid, carbohydrates) associated with 
neoplastic transformation. This chapter will present the investigation of the efficacy of 
random forests technique for Raman spectroscopic gastric dysplasia detection.  
8.1 RESULTS OF THE EMPLOYMENT OF RANDOM FOREST ALGORITHM FOR 
GASTRIC DYSPLASIA DETECTION 
In this study, the number of variables tested for each split was set to 23 (√544) and the 
error rate of different forest size from 1-1000 trees was investigated. Fig. 8.1 (a) 
demonstrated that the diagnostic algorithm stabilized after 284 trees were employed. 
Hence, we have selected to construct an ensemble of 285 trees to construct an optimal 
diagnostic algorithm. To illustrate the performance of this optimal diagnostic algorithm, 
ROC curve (Fig. 8.1 (b)) was generated by constructing different threshold levels from 
the probability associated with each data after the majority voting. The integration areas 
under the ROC curve is 0.950 for the forest size of 285 trees, proving the efficacy of this 
  109
 
 random forest algorithm derived for gastric dysplasia cancer diagnosis. The results show 
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Figure 8.1  (a) Different error rates belonging to different sizes of the random forests (i.e., 
different number of trees) after the voting process on all the tissue Raman spectra. 
Stabilization of forests occurred at 0.105 after more than 284 trees, illustrating that the 
random forests algorithm does not overfit. (b) ROC curve of tissue classification 
belonging to the final optimal random forests tree size of 1000 with an AUC of 0.950, 
illustrating the diagnostic ability of Raman spectroscopy and random forests algorithm to 
identify gastric dysplasia from normal gastric tissue. 
 
 
Figure 8.2 (a) displays the probabilistic classification results based on the random forests 
technique together with the leave-one sample (i.e., all spectra associated with the 
sample)-out, cross validation method. The random forests diagnostic algorithm yields the 
diagnostic sensitivity of 81.0%, and specificity of 92.7% for separating dysplasia from 
normal gastric tissues. In addition, Figure 8.2 (b) shows the variables importance plot 
based upon the construction of 1000 trees associated with gastric dysplasia 
transformation. The permutation accuracy importance measure notably reveals that 
Raman intensities at 875 (C-C stretching of hydroxyproline), 980 (ν (C-C) in α 
conformation of proline and valine), 1218 (C-C6H5 stretching mode of tryptophan and 
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 phenylalanine), 1302 (CH3CH2 twisting mode of proteins), and 1420 cm-1 (δ (CH2), δ 
(CH3) of proteins, δ (CH2) scissoring of phospholipids, deoxyriboses) are among the most 
important variables in the gastric tissue Raman spectra for distinguishing the dysplasia 
from normal. These results show that Raman spectroscopic technique combined with the 
random forests diagnostic algorithm is robust and powerful for gastric dysplasia 
diagnosis, and could provide interpretable Raman biomolecular information for the 
constructed diagnostic algorithm. 
 



























































Figure 8.2 (a) Scatter plot of the generated probabilistic scores belonging to the normal 
and dysplasia categories using the random forests technique together with leave-one 
sample-out, cross validation method. The separate line yields a diagnostic sensitivity of 
81.0% (17/21) and specificity of 92.7% (51/55) for differentiation between normal and 
dysplastic gastric tissue. (b) Variables importance plot for the Raman spectral region 800-
1800 cm-1 generated from random forests size of 1000 trees which was used for 
discrimination of dysplasia from normal gastric tissue. The variable importance algorithm 
defines the most important variable as 1, whereas the least important variable as 0. 




 8.2 COMPARISON OF PERFORMANCE AMONG INTENSITY RATIO, PCA-LDA, 
RANDOM FORESTS ANALYTIC ALGORITHMS FOR GASTRIC PRECANCER 
DETECTION  
To further evaluate and compare the performance of the different analytical algorithms 
constructed for gastric dysplasia detection, the ROC curves (Figure 8.3) from Figures 7.5 
and 8.1 (b) were plotted together, displaying the discrimination results for the three 
different diagnostic algorithms. A comparative evaluation of the ROC curves (i.e., ROC-
AUC) indicates that the PCA-LDA-based and random forests-based diagnostic algorithm 
can significantly give a more effective diagnostic capability as compared to the intensity 
ratio method for detection of gastric dysplasia from normal gastric tissues, as shown by 
the improvement in the diagnostic sensitivity and specificity. In addition, the ROC curve 
of PCA-LDA-based and random forests-based diagnostic algorithms appeared to be very 
similar, illustrating comparable diagnostic accuracy for detection of gastric dysplasia. 
The ROC-AUC for PCA-LDA-based and random forests-based diagnostic algorithm was 
0.98 and 0.95, respectively, confirmed that the two diagnostic algorithms achieved almost 
equivalent overall diagnostic accuracy for separating gastric dysplasia from normal 
gastric tissues. This result demonstrated that random forests-based diagnostic algorithms 
that utilized the entire spectral features of Raman spectra can yield comparable 
diagnostics accuracy as compared to PCA-LDA-based analytic algorithm, and a better 
diagnostic accuracy than the empirical approach for discriminating gastric dysplasia from 
normal tissues.  
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Figure 8.3 Comparison of ROC curves of discrimination results for Raman spectra 
utilizing the Raman intensity ratio of I875/I1450, PCA-LDA and the random forests 
algorithm. The integration areas under the ROC curves are 0.88, 0.98, and 0.95 for 
intensity ratio algorithm, PCA-LDA-based, and random forests-based diagnostic 
algorithm and intensity ratio algorithm, respectively, demonstrating the efficacy of PCA-
LDA algorithms for tissue classification. 
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Intensity ratio approach can only employ a limited number of Raman peaks for tissue 
diagnosis, most of the biomolecular information contained in the Raman spectra has not 
been used for spectral analysis. Since biological tissue is complex, it is likely that there 
are many biochemical species influencing diseases concurrently [12]. Therefore, 
sophisticated chemometrics techhnique such as PCA-LDA and random forests that 
utilizes the entire spectrum to determine the most diagnostically significant spectral 
features can improve the diagnostic efficiency of Raman technique for tissue analysis and 
classification. In this study, both techniques have been demonstrated to possess 
comparable diagnostic utility for gastric precancer diagnosis. Random forests technique 
 
 provides a unique advantage over the conventional PCA-LDA algorithm but furnishing 
distinctive spectral regions that are optimal for tissue differentiation can be identified and 
related to particular biochemical and biomolecular changes (e.g., proteins, nucleic acid, 
carbohydrates) associated with pre-neoplastic transformation. Note that only 5 prominent 
features are revealed to be of significant for precancerous lesion detection; where up to 
20 Raman features are found to be of diagnostic significant for diagnosing cancer 
(Chapter 4). The less Raman features revealed in the variable importance plot for 
precancerous lesions as compared to cancerous tissues indicated that there are less 
biomolecular changes involving the precancerous lesions as compared to the cancerous 
lesions. This is in agreement with histopathological signs of carcinogenesis 
transformation, whereby increase biomolecular activity will occur with the degree of 
neoplastic transformation [60]. Therefore, random forests could be a useful approach to 
identify the origins of biochemical/biomolecular changes of Raman spectra for tissue 
carcinogenesis analysis. This study confirmed the feasibility of NIR Raman spectroscopy 
in conjunction with random forests for providing diagnostic information necessary for 
distinguishing precancer from normal tissue.  
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 CHAPTER 9  
CONCLUSION AND FUTURE RESEARCH 
In this dissertation, we have demonstrated the feasibility of using an in-house developed 
NIR Raman system for human tissue characterization [12]. In order to facilitate 
identification of the origins of biochemical/biomolecular changes of Raman spectra for 
diseased tissue analysis, as well as providing high accuracy diagnostic algorithms for 
tissue classification, we have introduced the utilization of recursive partitioning technique 
with NIR Raman spectroscopy for detection of gastric cancer from normal gastric tissues 
[14]. To enhance the performance (i.e., stability and accuracy) of recursive partitioning 
technique, ensemble technique was also successfully deployed to be used with NIR 
Raman spectroscopy for cancer diagnosis [10]. We further assessed the diagnostic 
performance of random forests in comparison with the use of simplistic empirical method 
which employs Raman peak intensity ratios and multivariate statistical techniques (i.e., 
PCA-LDA) for gastric dysplasia diagnosis [12, 16]. ROC curves confirmed that PCA-
LDA and random forests techniques have comparable overall diagnostic accuracy rate 
which are more superior compared to the empirical approach for detection of gastric 
dysplasia from normal gastric tissues. Overall, this dissertation demonstrated the potential 
of NIR Raman spectroscopy with sophisticated chemometrics algorithms, particularly the 
random forests, to construct clinically interpretable diagnostic algorithm which can also 
yield high diagnostic accuracy for rapid diagnosis of precancer and cancer tissues based 




 In a clinical situation, there is often a need to determine the type of tissues into more than 
two groups such as various grades of tumor [11]. However, in this dissertation, we have 
only evaluated binary classification such as precancer vs. normal and cancer vs. normal. 
Further studies to investigate the possibility of simultaneously classifying Raman tissue 
spectra into more than two classes (e.g., normal vs. dysplasia vs. cancer) with different 
diagnostic algorithms [148, 149], especially the random forests are warranted. In addition, 
this study has only assessed the potential of Raman spectroscopy for dysplasia and cancer 
diagnosis. Evaluation on the feasibility of Raman spectroscopy for detection of diseases 
accompanying the entire carcinogenesis cascade before the onset of dysplastic changes 
should also be carried out [149]. Due to the limitation of size of the Raman probe used in 
the project, this dissertation has only focused on the evaluation of ex vivo tissues samples. 
With the development of miniaturized Raman probes for the collection of tissue Raman 
signals in a few seconds via endoscope, in vivo tissue Raman evaluation of the feasibility 
for detection of different lesions associated with cancer in the gastric and larynx ought to 
be carried out [50]. It is expected that NIR Raman endoscopic spectroscopy could be a 
clinically promising tool for the rapid, noninvasive, in vivo diagnosis and detection of 
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